curriculum vitae - arado€¦ · web view6th middle east quality management conference chairman...

CURRICULUM VITAE

PERSONAL INFORMATION

Name: Samer Ellahham, MD,CPHQ,CMQ,EFQM,FACC,FAHA,FACP

Date of Birth: August 16, 1961

Citizenship: U. S.

Home Address: Villa 17Karama AreaAbu Dhabi, UAE

Home Phone: 02-447-5654

Personal Cellular Phone: 056-329-7853

Personal E - Mail: [email protected]

UAE Business Addresses: Sheikh Khalifa Medical CityKarama StreetAbu Dhabi,UAE

UAE Business Phone: 02-819-2070

UAE Business Cellular Phone: 050-811-3142

UAE Business E-Mail: [email protected]

US Business Address: Cleveland Clinic FoundationInternational Operations1950 Richmond RoadLyndhurst, Ohio 44124

US Phone Number: 216-448-8250

US E-mail address: [email protected]

1

mailto:[email protected]



EDUCATION

1979 - 1982 AMERICAN UNIVERSITY OF BEIRUTBeirut, LebanonB. S. in Biology

1982 - 1986 AMERICAN UNIVERSITY OF BEIRUTSCHOOL OF MEDICINEBeirut, LebanonM. D. Degree

1986 - 1987 INTERNSHIPInternal MedicineGood Samaritan HospitalAn Affiliate of Johns Hopkins HospitalBaltimore, Maryland

1987 - 1988 RESIDENCYInternal MedicineGood Samaritan HospitalAn Affiliate of Johns Hopkins HospitalBaltimore, Maryland

1988 - 1989 RESIDENCYInternal MedicineWashington Hospital CenterWashington, D. C.

1989 - 1992 FELLOWSHIPDivision of CardiologyMedical College of VirginiaRichmond, Virginia

1991 - 1992 FELLOWSHIP Division of Heart Failure

Medical College of VirginiaRichmond, Virginia

1991 - 1992 FELLOWSHIP Division of Nuclear Cardiology


2

EDUCATION

1991 - 1992 RESEARCH FELLOWSHIP Division of Cardiology


1991 - 1992 CLINICAL INSTRUCTORCardiology DivisionMedical College of VirginiaRichmond, Virginia

1989 - 1992 MEDICAL HOUSE PHYSICIANJohnston Willis HospitalHenrico Doctors' HospitalRichmond, Virginia

PROFESSIONAL AND TEACHING EXPERIENCE

1992 - 1993 ASSISTANT PROFESSORDepartment of Internal MedicineEastern Virginia Medical SchoolNorfolk, Virginia

1992-1993 DIRECTOR, CORONARY CARE UNITHampton Veterans Affairs Medical CenterHampton, Virginia

1993 –1994 DIRECTOR, DIAGNOSTIC EXERCISE LABORATORY Washington Heart

Washington Hospital Center Washington, D.C.

1994 –2001 DIRECTOR, EXERCISE & PHARMACOLOGICAL STRESS TESTING IMAGING LABORATOR Washington Heart

Washington Hospital CenterWashington, D.C.

1997 – 2001 DIRECTOR, VASCULAR BIOLOGY LABORATORY Washington Heart Washington Hospital Center

Washington, D.C.

3

PROFESSIONAL AND TEACHING EXPERIENCE

1998- 2003 MEDICAL DIRECTOR, CARDIAC REHABILITATION National Rehabilitation Hospital Washington, D.C.

2001- 2003 DIRECTOR, CARDIOVASCULAR RESEARCHCardiothoracic InstituteGeorge Washington University Medical CenterWashington, D.C.

2002- 2008 TEACHING ATTENDINGGeorgetown University Medical CenterVHC/ Fairfax Hospital CampusWashington, D.C.

2001- Present DIRECTOR, PARAGON CARDIOVASCULAR FOUNDATIONFalls Church, Virginia

2006- 2007 MEDICAL DIRECTOR, INNOVATIVE MEDICAL INSTITUTEWashington, D.C.

2008- Present SENIOR CARDIOVASCULAR CONSULTANTSKMC Managed by The Cleveland Clinic FoundationAbu Dhabi, UAE

2009- Present CHIEF QUALITY OFFICERSKMC Managed by The Cleveland Clinic FoundationAbuDhabi, UAE

2009- Present CLEVELAND CLINIC UAE EXECUTIVE TEAMSKMC Managed by The Cleveland Clinic FoundationAbuDhabi, UAE

POST GRADUATE EDUCATION

Master of Public Health (MPH) ProgramPart-time Professional ProgramThe Johns Hopkins University School ofHygiene and Public HealthBaltimore, Maryland

4

CERTIFICATION

1987 ECFMG Certification: Valid indefinitely 1987 Maryland State Licence

1990 Diplomat of the American Board of Internal Medicine

1991 Advanced Cardiac Life Support (ACLS), Medical Director

1992 American Heart Association (AHA), Affiliate Faculty

1992 Nuclear Cardiology License

1993 Diplomat of the American Board of Internal Medicine

1994 Diplomat of the American Board of Cardiovascular Diseases 2005 Diplomat of the American Board of Cardiovascular Diseases,

Recertification

2007 SCCT CT Coronary Angiography Level I and II Certificate

2007 VNUS Certified in Total Vein Care

2007 SCCT CT Coronary Angiography Level III Certificate

2007 Vascular Imaging Certificate

2007 Diplomat, Vascular Medicine Board

2008 BLS

2008 ACLS

2010 Route Cause Analysis, Incident Mangement and Investigation

2010 Incident Reporting and Management

2012 Lean Six Sigma- Green Belt

2012 EFQM: Assessor 2013 Model

2013 Lean Certified in Healthcare

2013 Six Sigma - Black Belt

2014 ACLS Provider

2014 ACLS Instructor

5

CERTIFICATION

2015 National Institute of Health Research Certification

2015 Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ)

2015 Certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ)

MEDICAL LICENSURE

Licensed to practice medicine in Virginia, USA and Abu Dhabi, UAE.

PROFESSIONAL AFFILIATIONS

American Society of Nuclear Cardiology, Founding Member American College of Cardiology, Fellow American College of Physicians, Fellow American College of Chest Physicians, Fellow American Heart Association, Fellow American Society of Quality, Full Member American Medical Informatics Association, Member American Medical Association, Member American Diabetes Association, Member Apollo, Member International Society of Heart & Lung Transplantation, Member Jacobs Institute of Women's Health, Member Friends of American Medical Women Association (FAMWA) The American Society of Hypertension, Specialist in Hypertension Medical Society of District of Columbia, Member Heart Failure Society of America, Member Children’s Heart Link, Member Vascular Biology Working Group, Member Transcatheter Cardiovascular Therapeutics, Member Society of Chest Pain Centers, Member ACCP Sleep Medicine, Member NAAMA, Member Spirit of Women, Member Thrombosis Clinic, Member Pulmonary Vascular Disease Network, Member The National Coalition for Women with Heart Disease Society of Vascular Medicine , Member American Society of Echocardiography, Member The Erythromelalgia Association, Member The Fibromuscular Dysplasia Society of America, Member

6

PROFESSIONAL AFFILIATIONS

Lymphatic Research Foundation, Member The National Alliance for Thrombosis and Thrombophilia, Member The Adult Congenital Heart Association, Member Association for Professionals in Infection Control and Epidemiology, Member American Society For Quality, Full Member Agency for Healthcare Research and Quality, Member National Association for Healthcare Quality, Member Institute of Healthcare Improvement, Member Institute of Healthcare Improvement, Passport Member American Society of Quality, Member American Society of Medical Quality, Member National Association for Healthcare Quality, Member American College of Medical Quality, Member

HONORS AND AWARDS

1979 Dean's Honor List



1984 Honors in Internal Medicine, Surgery and Psychiatry

1985 Honors in Internal Medicine and Pediatrics

1992 Medical College of Virginia Fellow of the Year, Finalist

1992 DuPont Pharmaceuticals Research Award, ACCP 58th Annual Scientific Assembly, Young Investigator Award

1992 Alfred Soffer Research Award, ACCP 58th Annual

Scientific Assembly, Finalist 1994 American College of Chest Physicians, Fellow

1996 President, AAMA, Washington, D.C. Chapter

1996 International Who's WHO of Professionals, Member

1997 American Heart Association Council on Clinical Cardiology, Fellow

1997 American College of Physicians, Fellow

7

1998 Washington Hospital Center, Division of Cardiology, Teacher of The Year Award

HONORS AND AWARDS

1999 12th Annual Meeting of the Mediterranean Association of Cardiology & Cardiac Surgery, First Young Investigator Award

2000 Board Member, American Society of Hypertension,

Washington D.C. Chapter

2000 International Editorial Board Member, Hypertension Today Journal

2000 International Editorial Board of the Focus on Hypertension Journal

2001 Certificate of Appreciation, Department of US Army, Walter Reed Medical Center

2001 Medical Director, Paragon Cardiovascular Foundation

2004 HSANV Board Member: VA STATE Elected Official Position

2005 American Board of Internal Medicine, Cardiovascular Recertification

2006 International Editorial Board of the Focus On Hypertension Journal

2006 Mid-Atlantic American Society of Hypertension Board of Directors

2006 Reviewer of Pri-Med Institute, Cardiology Section

2006 Reviewer of Pri-Med Institute, Diabetes Section

2006 Medical Director – Innovative Medical Institute

2006 Dean Teaching Award, Georgetown University School of Medicine

2006 AHA Get with the Guidelines (GAP) Award

2005 Society for Simulation in Healthcare

2007 Faculty Pri-Med Institute

2008 First GWTG Heart Failure Center outside the US

2009 Editorial Board - Open Access Journal of Clinical Trials

2011 President, International Association of Healthcare Quality

2011 Certificate of Appreciation, Certified Professional In Healthcare Quality (CPHQ) Workshop

2011 SKMC, CEO Leadership Team Award

8

HONORS AND AWARDS

2011 Infection Prevention Day Award Infection Prevention Is Everyone's Business "In Recognition of your Support, Advocacy, & Influence for the Success of Infection Prevention Program"

2011 Third Annual SEHA Research Conference

2012 National Surgical Quality Improvement Program Executive Sponsor

2012 International Hand Hygiene Joint Commission Lean Sigma Project: Executive Sponsor

2012 Lean Six Sigma-Green Belt

2012 Expert Reviewer of HACA Standard Reviewer: Cardiac Program Certification Standards

2012 Joint Commission Center for Transforming Healthcare Award

2012 SKMC Infection Prevention Award: “In recognition of your dedicated efforts in the International Hand Hygiene Pilot Project for the Joint Commission Center for Transforming Healthcare as a project sponsor with highest level leadership”

2012 Meirc Training Award

2012 Fifth Edition of JCI Standards: JCI Standards Advisory Panel Member

2013 The United Arab Emirates Ministry of Health Patient Safety Award

2013 EFQM, Assessor 2013 Model

2013 Leader, SKMC SKEA Award Submission- Silver Award 2013 JCI Standard Advisory Panel Middle East Representative

2013 Lean Certified in Healthcare

2013 Six Sigma-Black Belt

2013 EFQM Risk Mangement Certified

2013 SEHA Transformational Event Diamond Award9

2013 SEHA Finalist Clinical and Quality Hall of Fame

HONORS AND AWARDS

2014 ACLS Instructor

2014 Cleveland Clinic Executive Visitor’s Program

2014 Fellow, Gulf Heart Association

2014 Appreciation from Quality Division of UAE Minitry of Health

2014 Certificate of Recognition for valuable contribution to SEHA Excellence Journey

2014 GCC Pharmaceutical Congress Dinstinguished Award

2014 Dubai Health Regulation Conference Award

2014 SKMC/CLEVELAND CLINIC Steering Committee/BoardCommendation for Exemplary Service

2015 SKMC Leader Dubai Quality Award Winner

2015 QUALITY LEADERSHIP AWARD from the World Quality Congress and Awards

2015 BUSINESS LEADERSHIP EXCELLENCE AWARD from World Leadership Congress

2015 Nominees for Safe Care magazine Person of the Year

2016 Clinical Transformation Event: Golden Award

2016 Operational Transformational Event: Golden Award

10

COMMITTEES

Chairman, Critical Care Equipment, Subcommittee, EVMS.

Member, Critical Care Committee, Hampton VA Medical Center.

Member, CCU Committee, Hampton VA Medical Center.

Member, Outcomes Initiative Committee, Washington Hospital Center.

Member, Washington Hospital Center Housestaff Recruitment Committee.

President and CEO - R & R Series Company, Inc.

Washington Heart Database Initiative, Member.

Washington Hospital Center Wellness Clinic, Member.

HSANV, Board Member.

Member, Data integrity Task Force, SKMC.

Member, Joint Service Review Committee (JSR), SKMC.

Member, Steering Committee, SKMC-SEHA.

Member, Research and Innovation Committee, SKMC.

Chairman, Search Committee for Chairman of Medicine, SKMC.

Chairman, Pressure Ulcer Prevention Team, SKMC.

Chairman, Accreditation and Compliance Committee, SKMC.

Chairman, JCI Executive Committee, SKMC.

Chairman, Quality Improvement and Patient Safety Committee, SKMC.

Chairman, International Patient Safety JCI Chapter, SKMC.

Chairman, Governance,Leadership and Direction JCI Chapter, SKMC.

Chairman, Quality and Patient Safety JCI Chapter, SKMC.

Chairman, Core-Measures/Clinical Starter Set Committee, SKMC.

Member, Senior Mangement Team, SKMC.

Member, Prevention and Control of Infection JCI Chapter, SKMC.

Member, Eduation JCI Chapter, SKMC.

Member, Research JCI Chapter, SKMC.

Member, Venous Thromboembolism Committee, SKMC.

Member, NSQIP Team, SKMC.

Member, Joint Service Review Team, SKMC.

Member, Peer-Review Committee, SKMC.

Member, Core Team, SKMC.

Member, Research and InnovationCommittee, SKMC.

11

Member City Governance, SKMC.

COMMITTEES

Member Strategic Committee, SKMC.

Member, Pain Management Committee, SKMC.

Member, Lenth of Stay Committee, SKMC.

Member, Health Promotion Committee, SKMC.

Member, Senior Management Council, SKMC.

Member, Infection Control Committee, SKMC.

Member, Medical Executive Council, SKMC.

Member, Chest Pain Accreditation, Steering Committee, SKMC.

Member, National Surgical Quality Improvement Team (NSQIP), SKMC.

Member, Health Information Committee, SKMC.

Member, Comprehensive Pain Mangement Committee, SKMC.

Member, BSP Operation Committee, SKMC.

Member, Data Integrity Task Force, SKMC.

Member, Operational Emergency Preparedness Committee, SKMC.

Member, Patient Experience Committee, SKMC.

Member, APIC.

Member, Position Control Team, SKMC.

Member, PGME, SKMC.

Member, Multi-payer Task Force. Member, Champion Documentation Project, SKMC. Member, SEHA/HAAD Health Audit Working Group. Member, Strategic Emergency Preparedness Committee, SKMC. Member, Grievance Committee, SKMC. Member, SEHA Quality Forum. Member, Chest Pain Accreditation Committee, SKMC. Member, SEHA Mortality and Morbidity Committee Member, SEHA Rapid Response Team. Member, Senior Mangement Council, SKMC. Member, Risk Management Committee, SKMC. Member, Environment Health & Safety Management System (EHSMS) Strategic Committee Member, Fifth Edition of JCI Standards: JCI Standards Advisory Panel Member. Member, CUSP/CLABSI Task Force, SKMC. Member, CAP Steering Committee Meeting, SKMC. Member, Medical Executive Committee, SKMC. Member, Clinical Chairs Committee, SKMC.

COMMITTEES

Member, Wellness Committee, SKMC.

Member, PSN Committee, SKMC.12

Member, PSN Committee, SEHA. Member, CAUTI Subcommittee, SKMC. Chairman, Transformation Event Team. Chairman, Real Time Patient Satisfaction Project. Chairman, Excellence SKMC Committee, SKMC. Chairman, EFQM SKMC Committee, SKMC. Chairman, Lean Six Sigma Performance Improvement Committee, SKMC. Chairman, Quality Champion Award, SKMC. Member, SSI Subcommittee, SKMC. Chairman, International Patient and Safety Goals. Chairman, EFQM/DQA Writing Group.

EDITORIAL RESPONSIBILITIES

Editor of The Journal of Safety and Quality of the Joint Commission

Editorial Board - Open Access Journal of Clinical Trials

Review for the International Journal of Quality & Reliability Management

Reviewer of Clinical Cardiology

Reviewer of manuscripts for Chest

13

Reviewer of manuscripts for the Lancet

Reviewer of manuscripts for Circulation

Reviewer of manuscripts for Diabetes Care

Reviewer of manuscripts for American Heart Journal

Reviewer of manuscripts for the Southerm Medical Journal

Reviewer of manuscripts for Archives of Internal Medicine

Reviewer of manuscripts for Annals of Internal Medicine

Reviewer of manuscripts for Endocrinology and Metabolism

Reviewer of manuscripts for European Journal of Heart Failure

Reviewer of manuscripts for Congestive Heart Failure Journal

Reviewer of manuscripts for the Journal of Nuclear Cardiology

Reviewer of manuscripts for the Journal of Transplant Coordination

Reviewer of manuscripts for the Journal of Cardiovascular Pharmacology

Reviewer of manuscripts for the Journal of American College of Cardiology

Reviewer of manuscripts of Saudi Heart Journal

SPORTS ASSOCIATIONS

American Medical Tennis Association, Member

United States Masters Swimming, Member

United States Tennis Association, Member

Peter Burwash International Special Tennis Programs, Member

United States Table Tennis Association, Member

Virginia Happy Trails Running Club, Member

American Running and Fitness Association, Member

LANGUAGES

Fluent in English, French and Arabic

PERSONAL INTERESTS

Sports, public speaking,teaching, research, reading, community service, cooking.

14

AWARDED GRANTS

1. The Role of Angiotensin in the pathophysiology of Atherosclerosis. Funding source: MEDLANTIC RESEARCH INSTITUTE.

2. Effect of a Soy on Brachial Reactivity in Post-menopausal Women.Funding source: PROTEIN TECHNOLOGY.

3. The effect of Non-selective Endothelin Receptor ET- A and ET-B Antagonism on The Endothelial Function of Chronic Heart Failure.Funding source: MEDLANTIC RESEARCH INSTITUTE.

4. Study of PDE5 Inhibition on Myocardial ischemia and Vascular Function. Funding source: MEDSTAR RESEARCH INSTITUTE.

15

SELECTED INVITED PRESENTATIONS

Risk Factors for Cardiovascular Disease and StrokeSupported by the American Heart AssociationFebruary 26, 1993Course Program DirectorHampton, VA

Washington Heart's Fifth Annual Symposium on EchocardiographyEchocardiography: Advances and Clinical Application. Stress Echocardiography versus Myocardial Perfusion Scintigraphyin Evaluation of Myocardial IschemiaSeptember 22-24, 1994Hyatt Hotel, Bethesda, MD

Washington Heart's Sixth Annual Symposium on Echocardiography:Advances and Clinical ApplicationsSymposium Co-directorStress Echo: Role in Evaluation of PTCA and Determination of Restenosis.September 22-24, 1995Hyatt Hotel, Bethesda, MD

South Medical Association's 90th Annual Scientific AssemblyNoninvasive Evaluation of the Cardiac Patient Undergoing Noncardiac Surgery.November 23, 1996Baltimore, MD

Washington Health and Fitness ExpositionRisk Factors of Coronary Artery Disease.January 25,1997Washington, DC

Bacos Middle School Cardiovascular PreventionJanuary 9, 1997Washington. DC

Department of Anesthesia Grand RoundWashington Hospital CenterPreoperative Cardiovascular Risk Assessment.April 8, 1997Washington, DC

Management of Chronic Mitral Regurgitation in the Modern EraEtiology and Pathophysiology of Chronic Mitral Regurgitation:Interesting Cases.May 31, 1997Washington, DC

16


Innovations in Medicine and Surgery19th National AAMA ConventionProgram Committee.New Concepts in Cardiac DiseaseWashington, DC

Moderator: Research Award Presentations. Willard HotelAugust 28-31, 1997Washington, DC

Pharmacological Innovations in The Management of Hypertension and AnginaFour Seasons HotelSeptember 3, 1997Washington DC

Echocardiography: The How-To of Image Acquisition and QuantitationTeleconference American College of Cardiology: Heart HouseSeptember 13,1997Bethesda, MD

New Therapies for the Treatment of Hypertension and AnginaNorthern Virginia Society of OsteopathsSeptember 16, 1997Mc Lean Hilton, VA

Pharmacological Innovations in The Management of Hypertension and Angina September 21, 1997

Tysons Corner Ritz Carlton, VA

Update on The diagnosis and Treatment of Congestive Heart FailureSeptember 23, 1997 Mount Vernon Hospital Grand Round, VA

Biosence: Diagnostic and therapeutic Applications Direct PercutaneousMyocardial Revascularization (DMR)September 15, 1997Washington Hospital CenterWashington, DC

Relief of Septal Obstruction in Hypertrophic Cardiomyopathyby Transient Occlusion of The First Septal Branch of the Left Anterior Artery and Septal Reduction With Desiccated Ethanol Instillation-Live DemonstrationTCTSeptember 16, 1997 Washington, DC

17


Transesophageal Echocardiographically-Guided Balloon Mitral Valvuloplasty“Live Demonstration"Transcatheter Cardiovascular Therapeutics (TCT) September 24- 28, 1997Washington, DC

Preoperative Cardiovascular Risk assessmentMedical Grand RoundOctober 17, 1997Prince George HospitalCheverly, MD

Pharmacological Innovations in The Management of Hypertension and Angina October 23, 1997

Old TownFredericksburg, MD

Update on The Diagnosis and Treatment of Congestive Heart FailureMedical Grand Round October 29, 1997DC General HospitalWashington, DC

Pharmacological Innovations In the Management of Hypertension and Angina November 4, 1997

Baltimore, MD

Update on The Diagnosis and Treatment of Congestive Heart FailureMedical Grand Round November12, 1997Potomac HospitalWoodbridge, VA

Pharmacological Innovations In the Management of Hypertension and Angina November 18, 1997

GeorgetownWashington, DC

Cardiac Contagion: Chlamydia Pneumoniae and Coronary Artery DiseaseMedical Grand RoundOctober 17, 1997 Prince George HospitalCheverly, MD

18


Congestive Heart FailureNurse Practitioner ConferenceDecember 10, 1997Washington Hospital CenterWashington, D.C.

Clinical Advantages of T-type Calcium Channel Blocking AgentsMedical Grand RoundsDecember 12, 1997 Andrews Air force Base, VA

The Latest Anti-Hypertensive Therapies for Difficult to Regulate PatientsAnd the African-American Population January 8, 1998California, Maryland

Cardiac Contagion: Chlamydia Pneumoniae and Coronary Artery DiseaseMedical Grand Rounds Washington Hospital CenterJanuary, 21, 1998Washington, D.C.

New Therapies For Hypertension and Angina February 17, 1998

GeorgetownWashington, D.C.

T-Channel Science and a New Compound For Treating Hypertension Angina February 20, 1998

Oxford, Maryland

New Approaches to Cardiovascular Therapy: T-Type Calcium Channel Blocker in Cardiovascular TherapyKey Note Speaker, NVCNP MeetingMarch 12, 1998Falls Church, Virginia

New Advances in Antiplatelet TherapyNational Medical Naval CenterMarch 27,1998Bethesda, Maryland

New Trends in Antiplatelet Therapy April 16,1998

Baltimore, Maryland

19


Neutral Endopeptidase Inhibitors in Heart FailureVascular Biology ConferenceApril, 17, 1998Washington Hospital CenterWashington, D.C.

Update on Congestive heart Failure April 23, 1998

Fort Belvoire Medical Grand Round, Virginia

New Trends in Antiplatelet Therapy April 23, 1998

Ann Arundel Hospital Medical grand RoundAnnapolis, Maryland

New Advances in Antiplatelet Therapy May 5, 1998

Bethesda, Maryland

New Approaches to Cardiovascular Therapy: T-Type Calcium Channel Blocker in Cardiovascular Therapy

May 9, 1998Atlantic City, New Jersey

New Trends in Antiplatelet TherapyMay 12, 1998 GeorgetownWashington, D.C.

What’s New in Anti-platelet TherapyMedical Grand Round University of Maryland May 27, 1998Baltimore, Maryland

Management of Valvular Heart Disease in the Modern EraEtiology and Pathophysiology of Chronic Mitral Regurgitation.Interesting Cases.May 29-30, 1998Washington, D.C.

New Advancements In The Treatment of Hypertension and Angina May 30, 1998

Richmond, Virginia

Update on Antiplatelet Management June 2, 1998

Luthersville , Maryland

20


Update on Congestive Heart FailureMedical Grand RoundGreater South East HospitalJune 3, 1998Washington, D.C.

JNC VIWashington Hospital CenterJune 4, 1998Washington, D.C.

Antiplatelet ManagementMedical grand RoundJune 5, 1998Adventist Hospital , Maryland

Update on Antiplatelet Therapy June 22, 1998

Baltimore, Maryland

Update on Antiplatelet TherapyCardiology Rounds, Johns Hopkins Hospital June 29, 1998Baltimore, Maryland

New Advances in Antiplatelet TherapyMedical Grand Rounds, Saint Joseph’s HospitalJuly 15, 1998Baltimore , Maryland

Treating the Difficult Hypertensive PatientsHoly Cross Department of Family Practice CMEOctober 5, 1998Wheaton, Maryland

Evidence of Chalmydia Pneumoniae as a Risk Factor For Coronary Artery Disease:Status of Ongoing Antibiotic Clinical TrialsTranscatheter Cardiovascular TherapeuticsTenth Annual SymposiumOctober 8, 1998Washington, D.C.

Relief of Septal Obstruction in Hypertrophic Cardiomyopathy by Transient Occlusion of The First Septal Branch of the Left Anterior Artery and Septal Reduction With Desiccated Ethanol Instillation-Live demonstrationLeft Ventricular Volume Reduction Surgery- Live DemonstrationTranscatheter Cardiovascular Therapeutics (TCT), October 10, 1998

21

Washington, D.C.SELECTED INVITED PRESENTATIONS

Understanding Myocardial Viability: Dobutamine Stress Echocardiography Biosense LV Electromechanical Maps Training Course Transcatheter Cardiovascular TherapeuticsTenth Annual SymposiumOctober 11, 1998Washington, D. C.

New Advances in Oral Antiplatelet Therapy November 5, 1998

Washington, D. C.

Advances in the Prevention of Ischemic Vascular Events: Antiplatelet Agents in Acute Coronary Syndromes.ASHP Midyear Clinical Meeting, December 6, 1998 Las Vegas, Nevada

Update on Antiplatelet therapy.Cardiology Grand RoundsGood Samaritan HospitalJanuary 12, 1999 Baltimore, MD

Endothelium, platelets and antiplatelet therapyCardiovascular pathophysiology conferenceHoward University Medical CenterFebruary 3, 1999Washington, D.C.

Stress EchocardiographyWashington Hospital Center Grand Rounds February 10, 1999 Washington, D.C.

Update on Antiplatelet trials: CURE and SYMPHONY IIWashington Hospital Center Emergency Room RoundsFebruary 18, 1999Washington, D.C.

Coronary Artery Bypass Surgery and AngioplastyNational Rehabilitation Hospital RoundsFebrurary 18, 1999 Washington, D.C.

New Trends In Cardiovascular Risk factors February 18, 1999


22


Cardiac RehabilitationNational Rehabilitation Hospital Grand RoundsFebruary 26, 1999Washington, D.C.

New cardiovascular Risk Factors: Homocysteine April 9, 1999

Washington hospital CenterWashington, D.C.

Update on Antipaltelet TherapyApril 8,1999 Washington, D.C.

National Antiplatelet Therapy Update MeetingModerator April 11-12, 1999Naples, Florida

Update on Antipaltelet Therapy May 21,1999

Pennsylvania

Update on theTtreatment of Obesity June 15,1999

Richmond, VA

Moderator: Cardiology Morning Session, NAAMA 16th International Medical Convention July 1999Beirut, Lebanon.

Obesity and Heart Disease August 4,1999

Alexandria , VA

Evolving Treatment of Acute Coronary Syndromes: New Agents and ApplicationsCourse DirectorSeptember 8, 1999Baltimore, Maryland

Endothelial Dysfunction in Hypertensive PatientsVascular Biology ConferenceWashington Hospital CenterSeptember 10,1999Washington, D.C.

23


Obesity and Heart September 14,1999

Bethesda, Maryland

Update on Vascular BiologyCardiology Grand RoundsHoward University Medical CenterSeptember15, 1999Washington, D.C.

AtherosclerosisNational Rehabilition HospitalSeptember 21,1999Washington, D.C.

Endothelium, Platelets and Antiplatelet therapy October 12,1999

Baltimore, MD

Chairman: Basic Science12th Annual MeetingOctober 19-22, 1999Mediterranean Association of Cardiology and Cardiac SurgeryDamascus, Syria

Angiotensin and the Endothelium November 4, 1999


Angiotensin and the Endothelium December 7, 1999

Washington, D.C.

The Patient With Atherothrombosis: Preventing Ischemic Event December 15, 1999

Walter Reed Army Medical Center Neurology Grand RoundsWashington, D.C.

Current Management of Myocardial InfarctionDecember 17, 1999 National Institute of HealthBethesda, MD

Endothelin Inhibitors and Heart Failure:Vascular Biology ConferenceSeptember 15, 2000 Washington Hospital Center

24

Washington, D.C.SELECTED INVITED PRESENTATIONS

Inflammation, HsCRP and Atherosclerosis:Vascular Biology ConferenceOctober 13, 2000Washington Hospital CenterWashington, D.C.

Exercise and Heart Failure:Endothelial mechanisms for symptomatic improvement

Vascular Biology Conference November 17, 2000 Washington Hospital Center

Washington, D.C.

Aldosterone Receptor Antagonists and Heart FailureVascular Biology ConferenceDecember 15, 2000Washington Hospital CenterWashington, D.C.

Vasopeptidase Inhibitors and Heart FailureVascular Biology ConferenceJanuary 19, 2001Washington Hospital CenterWashington, D.C.

Antiplatelet Therapy Managed Care Clinical Forum:Atherosclerotic Disease and Antiplatelet TherapyFebruary 15, 2001 Baltimore, Maryland

Peripheral Arterial DiseaseVascular Biology ConferenceFebruary 16, 2001 Washington Hospital CenterWashington, D.C.

Exercise and Heart FailureMedical Grand RoundNational Rehabilitation HospitalMarch 2, 2001Washington, D.C.

25


Pregnancy and the HeartPathophysiology ConferenceMarch 16, 2001Washington Hospital CenterWashington, D.C.

Update on Antiplatelet TherapyMedical Grand RoundMarch 21,2001DC General HospitalWashington, D.C.

Hyperthyroid Heart DiseaseMarch 23,2001North Arundel Hospital, MD

Update on Heart Disease : Diagnosis and Treatment March 25, 2001

Northern VA AAMA Community Outreach Fairfax , VA

Common Cardiac Diagnoses April 2, 2001

National Rehabilitation HospitalWashington, D.C.

Components of a Complete TEE: Technical Tips and PearlsWashington Hospital CenterApril 12, 2001Washington, D.C.

Atherosclerotic Cardiovascular Disease: An update July 31, 2001

Saint Petersburg, Florida

Managed Care and Antiplatelet TherapyAugust 1, 2001 Dearbon, Michigan

Oral Antiplatelet Therapy: An UpdateMedical Grand RoundAugust 3, 2001 Prince George County Hospital, Maryland

Oral Antiplatelet Therapy: An UpdateAugust 7, 2001 Phoenix, Arizona

26


Exercise and Heart FailurePNMR Grand RoundAugust 20, 2001Walter Reed Army Medical CenterWashington, D.C.

Peripheral Artery Disease: Diagnosis & ManagementAugust 14, 2001 Buffalo, New York

Oral antiplatelet TherapyAnd Acute Coronary SyndromeFamily Medicine Grand RoundAugust 15, 2001Howard University Medical CenterWashington, D.C.

Oral Antiplatelet Therapy and Managed CareAugust 16, 2001 Washington, Seattle

Antiplatelet Therapy and Acute Coronary SyndromeMedical Grand RoundsKimberough Medical CenterSeptember 5, 2001 Fort George G. Meade, Maryland

Management of Acute Coronary SyndromesPrince George HospitalMedical Grand RoundOctober 17, 2001Prince George County, MD

Management of Acute Coronary SyndromesGood Samaritan HospitalMedical Grand RoundOctober 22, 2001Baltimore, MD

Management of Acute Coronary SyndromesOctober 24, 2001 Baltimore, Maryland

Acute Coronary Sydromes October 26, 2001

Andrews Airforce Base Medical CenterMaryland

27


Update on the Management of Acute Coronary SyndromesNovember 7, 2001 Washington, D.C.

Atherothrombosis Summit Course DirectorEpidemiology and Pathophysiology of AtherothrombosisAdvances in the Management of Vascular EventsTreatment Modalities of Acute Coronary SyndromesHigh-Risk Patient WorkshopNovember3-4, 2001 Atlanta, Georgia

Oral Antipaltelet Therapy and Acute Coronary SyndromeMarch 22, 2002 Washington, D.C.

Update on the Management of Acute Coronary SyndromesMarch 23, 2002 Hanover, Maryland

Update on the Management of Acute Coronary SyndromesApril 4, 2002 Holidaysburg, Pennsylvania

Update on Intaroperative Transesophageal EchocardiographyAnesthesia Grand RoundGeorge Washington University Medical CenterApril5,2002 Washington, D.C.

Acute Coronary SyndromesMedical Grand RoundHoward University Medical CenterApril17,2002 Washington, D.C.

Acute Coronary SyndromesEmergency Room Grand RoundProvidence HsopoitalApril17,2002 Washington, D.C.

28


Exercise and Heart FailureMedical Grand RoundsMay 3, 2002Virginia Hospital CenterArlington,Virginia

Update on Systemic Hypertension May 15, 2002

Wilimington, Delaware

Update on Systemic HypertensionMay 17, 2002 Delaware Beach, Delaware

Update on Systemic Hypertension

May 17, 2002 Rebobath Beach, Delaware

Update on the Management of Acute Coronary SyndromesMarch 23, 2002 Hanover, Maryland

Update on Systemic HypertensionJune 5, 2002 Delaware Beach, Delaware

Update on Systemic HypertensionMay 6, 2002 Newark, Delaware

Update on Management of HyperlipidemiaJune 6, 2002 Ocean City, Maryland

Hyperlipidemia: What’s New?Ritz CarltonJune 18, 2002Tyson’s Corner, Virginia

Update on the Management of Acute Coronary Syndromes June 24, 2002

California, Maryland

Update on Systemic Hypertension for the Community July 8, 2002

Virginia Hospital CenterArlington, VA

29


Update on the Management of Acute Coronary SyndromesAugust 27, 2002 Atlanta, Georgia

Update on the Management of Acute Coronary SyndromesJune 24, 2002 Miami, Florida

Update on Systemic HypertensionSeptember 10, 2002 Falls Church, Virginia

Update on the Management of Acute Coronary Syndromes September 13, 2002

Howard University Medical CenterWashington, D.C.

Management of Systemic Hypertension in Diabetic PatientsJanuary 30,2003Chevy Chase, MD

Advances in the Management of Patients with Acute Coronary SyndromesInova Alexandria Hospital Medical Staff MeetingFebruary 4,2003Alexandria, VA

Update on the Management of Acute Coronary SyndromesCenter Community HospitalFebruary 12, 2003State College, PA

Update on the Management of Systemic Hypertension in Patients with Diabetic Nephropathy

February 26, 2003Vienna, VA

Acute Coronary Syndromes: Update on the AHA/ACC GuidelinesProvidence HospitalMarch 27, 2003Washington, D.C.

New ACC/AHA Guidelines: Management of Acute Coronary Syndrome PatientsPhilippino American Medical Society March 30, 2003Baltimore, MD

Update on the Management of Acute Coronary Syndrome March 31, 2003

Baltimore, MD

30


Acute Coronary Syndromes: Focus on NSTEMI/UAApril 1, 2003Cincinatti, Ohio

Acute Coronary Syndromes: Focus on Antipltelet TherapyApril 2, 2003Cincinatti, Ohio

Acute Coronary Syndromes: New ACC/AHA GuidelinesApril 3, 2003Cincinatti, Ohio

Update on Antiplatelet TherapyApril 11, 2003Somerset Area Hospital Somerset, Pennsylvania

Update on the Management of Patients with Chronic Heart FailureApril 18, 2003Georgetown University Medical Center Washington, D.C.

Update on the Management of Hypertension in Patients with Diabetic NephropathyApril 23, 2003Charlottesville, VA

Management of Patients with Hypertension and Diabetes MellitusMedical Grand RoundMay 9, 2003Vrginia Hospital CenterArlington, VA

Systemic Hypertension in Patients with Diabetic Nephropathy May 13, 2003

Tyson’s corner, VA

Advances in the Management of Acute Coronary Syndromes and Changes in the ACC/AHA Guidelines: CME ProgramMay 14, 2003 State College, PA

Update on the Management of Hyperlipidemia in Patients with Coronary Artery DiseaseMay 19, 2003 Baltimore, MD

New Trends in the Acute and Long-term Management of Patients with Acute Coronary Syndromes

May 27, 2003 Johnstown, PA

31


Management of Patients with Hypertension and Diabetes MellitusK. Memorial Center, Housestaff ConferenceMay 28, 2003Johnstown, PA

Update on the Management of Patients with Hypertension and Diabetes Mellitus

May 28, 2003 Johnstown, PA

Management of Patients with Peripheral Artery DiseaseJune 2, 2003Philsburg, PA

Acute Coronay Syndromes: New ACC/AHA GuidelinesJune 4, 2003 East Petersburg, PA

New Trends in the Evaluation and Management of Patients with Acute Coronary Syndrome: Medical Grand Round, Conemaugh Memorial Hospital

June 6, 2003Johnstown, PA

Acute Coronary Syndrome: Update on Antithrombotic TherapyJune 11, 2003Mount Carmel, PA

The Long Term Management of Diffuse AtherothrombosisNurse Practitioner Society of MarylandJune 12, 2003Bethesda, Maryland

Antiplatelet Therapy: Focus on Acute Coronary SyndromesJune 18, 2003 Johnston City, TN

Antiplatelet Therapy: Focus on Acute Coronary SyndromesJohnston City Medical CenterCardiac Catheterization ConferenceJune 18, 2003Johnston City, TN

Management of Patients with Acute Coronary Syndromes: Case Discussion and UpdateJune 24, 2003Radnor, PA

Update on Diagnosis and Treatement of DyslipidemiaMay 19, 2004 Southern Maryland

32


Update on Dyslipidemia May 21, 2004 Fairafx, VA

New Trends in the Diagnosis and Management of Acute Coronary SyndromeMedical Grand RoundJune 2, 2004 York Memorial HospitalYork, Pennsylvania

Update on the Management of Acute Coroanry SyndromeCardiology Grand RoundJune 5, 2004 Hershey Medical CentreHershey, Pennsylvania

Acute Coronary SyndromesJune 9, 2004 Harrisburg, PA

Acute Coronary SyndromesMedical Grand RoundDu Bois Medical CenterJune18, 2004Du Bois, PA

Advances in the Diagnosis and Management of Acute Coronary SyndromeAugust 3, 2004 Pittsburg, PA

Longterm Treatment of Patients with Acute Coronary SyndromeAugust 4, 2004 Cleveland, Ohio

New trends in the Magement of Acute Coronary SyndromeAugust 4, 2004Cleveland, Ohio

Update on Chest Pain Diagnosis and ManagementMedical Grand RoundRadar ClinicAugust 18, 2004Arlington, VA

Update on Peripheral Arterial DiseaseCardiology Grand RoundElmhurst Hospital CenterAugust 19, 2004 Elmhurst, NY

33


A Risk-Based Approach to Managing Patients With Cardiovascular Disease (CME)Medical Grand RoundYork Memorial HospitalFebruary 2, 2005York, PA

A Risk-Based Approach to Managing Patients With Cardiovascular Disease (CME)Medical Grand RoundGettysburg HospitalFebruary 5, 2005Gettysburg, PA

Longterm Management of Acute Coronary Syndrome PatientsWrightsville, PAFebruary 7, 2005

Discussion on the Management of Acute Coronary Syndromes February 10, 2005

Lancaster, PA

Update on Acute Coronary SyndromesCardiology Garnd RoundSunny Downstate University HospitalFebruary 22, 2005Brooklyn, NY

Update on Acute Coronary Syndromes: Preoperative and postoperative careCardiac Surgical Intensive Care Unit RoundSunny Downstate University HospitalFebruary 22, 2005Brooklyn, NY

Update on Acute Coronary Syndromes February 22, 2005

Long Island, NY

Advances in the Management of Acute Coronary SyndromesMarch 1, 2005Harrisburg, PA

Advances in the Management of Acute Coronary SyndromesMarch 9, 2005Great Neck, NY

Advances in the Management of Acute Coronary SyndromesMarch 10, 2005Garden City, NY

34


Advances in the Management of Acute Coronary SyndromesSurgical Grand RoundBrookdale HospitalMarch 13, 2005Brooklyn, New york

Advances in the Management of Acute Coronary SyndromesMarch 15, 2005Windber, PA

Advances in the Management of Acute Coronary SyndromesSurgical Grand RoundBrookdale HospitalMarch 24, 2005Brooklyn, NewYork

Managing the Broad Range of High Risk PatientsSeptember 6, 2005Centerville, Virginia

Update on The Management of Acute Coronary SyndromeNovember 16th, 2005Miami Beach, FL

Understanding Hypertension and Type 2 Diabetic Nephropathy with HypertensionJanuary 19th, 2006 Fort Washington, MD

Understanding Hypertension and Type 2 Diabetic Nephropathy with HypertensionNOVA Internal Medicine& Urgent CareJanuary 20th, 2006 Ashburn, VA

Understanding Hypertension and Type 2 Diabetic Nephropathy with HypertensionJanuary 26 th, 2006 Annapolis, MD

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskMarch 2, 2006 Winchester,Virginia

Advances in Heart Failure Therapy:March 3, 2006 Frederick, Maryland

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.Primed UpdateMarch 4, 2006

Pittsburg, Pennsylvania

35


Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.Primed UpdateMarch 7, 2006

Atlanta, Georgia

Understanding Hypertension and Type 2 Diabetic Nephropathy with HypertensionMarch 8, 2006 Falls Church, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskMarch 9, 2006

New Brunswick, New Jersey

Understanding Hypertension and Type 2 Diabetic Nephropathy withHypertensionMarch 13, 2006

Alexandria, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskMarch 21, 2006 LaPlata,Maryland

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskMarch 23, 2006 Maimi Beach, Florida

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskMarch 24, 2006 Miami, Florida

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskSouth Miami HospitalMarch 24, 2006 Miami ,Florida

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.Primed UpdateMarch 27, 2006Houston, Texas

Understanding Hypertension: Prevalence, Guidelines and RisksMarch 29, 2006Annapolis, Maryland

Advances in Heart Failure Therapy:March 30, 2006 Frederick, Maryland

36


Understanding Hypertension and Type 2 Diabetic Nephropathy with HypertensionApril 3, 2006 Midlothian, Virginia

Key Note SpeakerCareer DayNational Honor SocietyApril 11, 2006 Alexandria, VA

Confront the Challenge: Treating Patients to Their Dylipidemia Goals April18, 2006 Olney, Maryland

Understanding Hypertension: Prevalence, Guidelines and RisksApril 19, 2006 LaPlata, Maryland

Understanding Hypertension and Type 2 Diabetic Nephropathy with HypertensionApril 25, 2006 Saint Michaels, Maryland

Optimizing Treatment of Dyslipidemia in Patients with Type 2 Diabetes MellitusAnnapolis Internal MedicineApril 26, 2006 Annapolis, Maryland

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.Primed UpdateApril27, 2006 Saint Loius, MO

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskMay 3, 2006 Clifton Springs, New York

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.Primed UpdateMay 5, 2006 Norfolk, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskMay16, 2006 Hagerstown, Maryland

Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.Primed UpdateMay 18, 2006 Allentown, Pennsylvania

37


Visceral Fat an Emerging Endocrine Organ: Effects on Cardiometabolic Risk.Primed UpdateMay 20, 2006 East Rutherford, New Jersey

STEMI Management Strategies for Non-Cath-Lab Hospitals ProgramJune 1, 2006 Clarksburg, West Virginia

Advances in Heart Failure Therapy:June 3, 2006 Vienna, Virginia

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskJune7, 2006 Frederick, Maryland

Insulin Therapy in Treating Critically Ill Patients: What are the Potential Benefits?Primed Cardiology UpdateJune 10, 2006 Itasca, Illinois

Managing the Broad Range of High Risk PatientsJune 13, 2006 Arlington, Virginia

Peripheral Arterial Disease: Identification and Mangement of RiskWilliamsport HospitalJune 15, 2006 Williamsport, Pennsylvania

Visceral Fat an Emerging Endocrine Organ: Effects on cardiometabolic risk.Primed UpdateJune 17, 2006 Vienna, Virginia

Update on Atheroscerolic Peripheral Arterial DiseaseAugust 16, 2006 Bricktown, New Jersey

Advanced Management of Cardiovascular Disease: Reducing the Burden of RiskFranklin Square HospitalAugust29,2006 Baltimore, MD

Understanding Hypertension: Prevalence, Guidelines and RisksAugust 31, 2006 Richmond, VA

38


A Novel Approach to Cardiometabolic Risk Reduction: Role of the Endocannabinoid SystemAtlanta VA Medical CenterEmory University Hospital AffiliateSeptember 7, 2006Atlanta, Georgia

Understanding Hypertension:Prevalnce, Guidelines and RisksSeptember 12, 2006 Lexington Park, Maryland

Understanding Hypertension:Prevalnce, Guidelines and RisksSeptember 14, 2006 Buffalo, New York

Primary and Secondary Stroke Prevention:Pathways of CareGreenville Memorial HospitalRehabilitaion Grand RoundSeptember 16,2006 Greenville, South Carolina

Adavanced Management of Cardiovascular Disease: Reducing the Burden of RiskCardiac Catheterization ConferenceHarrisburg HospitalSeptember 18, 2006 Harrisburg, Maryland

Acute Coronary SyndromeKrembs Cardiac Teaching DayContinuing Medical EducationSeptember 21, 2006 Binghampton, New York

Adavanced Management of Cardiovascular Disease: Reducing the Burden of RiskSeptember 26, 2006 New Milford, New Jersey

Management of Patients with STEMI:Applying the ACC/AHA GuidelinesContiniung Medical EducationMedical Grand RoundSptember 26, 2006New Milford, New Jersey

Bergen Regional Medical CenterSeptember 27, 2006 Paramus, New Jersey

39


In-Hospital Hyperglycemia in Type 2 Diabetes Edirorial Working GroupNSTEMI UpdateOctober 20, 2006 Atlanta, Georgia

A Novel Approach to Cardiometabolic Risk Reduction: Role of the EndocannabinoidSystemPrimed MeetingOctober 27, 2006 Durham, North Carolina.

Management of ST-Elevation Myocardial Infarction: Focus on the ThrombolyticApproach.December 5, 2006 Manassa, VA

Insulin Therapy in Treating Critically Ill Patients: What are the Potential Benefits?Primed Cardiology UpdateDecember 9 , 2006 Miami, Florida

Management of Patients With STEMI: Applying the ACC/AHA GuidelinesSamaritan Medical CenterDecember 11, 2006Watertown, NY

Management of Patients With STEMI: Applying the ACC/AHA GuidelinesWashington, D.C.December 12, 2006.

Management of Patients With STEMI: Applying the ACC/AHA GuidelinesDecember 12, 2006Waterville, ME

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceJanuary 9, 2007Washington, D.C.

Management of Patients With STEMI: Applying the ACC/AHA GuidelinesMontgomery General HospitalJanuary 11, 2007 Olney, Maryland

Acute Coronary Syndrome: Non- ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceJanuary 17, 2007Washington, D.C.

40


Acute Coronary Syndrome: Non- ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceJanuary 23, 2007 Washington, D.C.

Acute Coronary Syndrome: Non- ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceJanuary 26, 2007Washington, D.C.

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceFebruary 1, 2007Washington, D.C.

Management of Patients With STEMI: Applying the ACC/AHA GuidelinesMontgomery General HospitalVAMCFebruary 2, 2007 Wilkes Barr, PA

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceFebruary 7, 2007Washington, D.C.

A Novel Approach to Cardiometabolic Risk Reduction: Role of the EndocannabinoidSystemMedical Grand RoundFebruary 8, 2007 Dalton, GA

Management of Patients With STEMI: Applying the ACC/AHA GuidelinesGreater South East Community HospitalFebruary 14, 2007 Washington, D.C.

Update on Peripheral Arterial DiseaseFebruary 16, 2007 West Palm Beach, FL

New Data on Acute Coronary SyndromesCardiac Cath ConferenceJFK Medical CenterFebruary 17, 2007 Atlantis, Florida

41


Update on AtherothrombosisDepartment of Medicine RoundPrince George HospitalFebruary 20, 2007 Hyatsville, Maryland

A Novel Approach to Cardiometabolic Risk Reduction: Role of the EndocannabinoidSystemSalisbury HospitalMedical Grand RoundFebruary 27, 2007Salisbury, MD

Update on Atherothrombosis: Make the ConnectionMarch 1, 2007 Rochester, New York

Update on Hypertension:March 6, 2007 Emporia, VA

Update on HypertensionMarch 8, 2007 Rochester, New York

New Data on Acute Coronary SyndromesMarch 15, 2007 Johnstown, PA

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceMarch 19, 2007 Washington DC

Atherothrombosis and Peripheral Arterial Disease: Making the ConnectionMarch 20, 2007 Bethesda, Maryland

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceMarch 20, 2007 Washington, D.C.

Coronary Interventions in Acute Coronary Syndrome Clara Mass Medical Center March 21, 2007Newark, NJ

42


Atherothrombosis: New Data on Acute Coronary SyndromeMarch 21, 2007 Paramus, NJ

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceMarch 22, 2007 Washington, D.C.

Atherothrombosis: New Data on Acute Coronary SyndromeMarch 22, 2007 New Castle, PA

Atherothrombosis: New Data on Acute Coronary SyndromeMarch 22, 2007 Erie, PA

Atherothrombosis Make The Connection: A Focus on Peripheral Arterial Disease.March 22, 2007 Leesburg, VA

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceApril 3, 2007 Abu Dhabi, UAE

Diabetes and Cardiovascular Disease: Glycemic Control and Insulin Therapy. Medical Grand Rounds SKMC Medical Center April 5, 2007 Abu Dhabi, UAE

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceApril 12, 2007Abu Dhabi, UAE

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceApril 17, 2007

Abu Dhabi, UAE

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceApril 19, 2007 Abu Dhabi, UAE

Treatment Startegies for Hypertensive Patients Not at Their Goal on One AgentNational Expert Exchange TeleconferenceApril 23, 2007Abu Dhabi, UAE

43

SELECTED INVITED PRESENTATIONS Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes

National Expert Exchange TeleconferenceApril 24, 2007Abu Dhabi, UAE

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceApril 26, 2007Abu Dhabi, UAE

Acute Coronary Syndrome: ST Elevation Myocardial Infartcion

National Expert Exchange TeleconferenceMay 1, 2007Washington DC

Acute Coronary Syndrome: Best Practices in Acute Coronary Syndromes National Expert Exchange Teleconference ay 3 , 2007 Washington DC

Treatment Strategies in Patients with Hypertension Who are Not at their Blood Pressure Goal

May 8, 2007 Fredricksburg, VA

Atherothrombosis and Acute Coronary SyndromesMay 9, 2007

Cumberland, MD

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceMay 10 , 2007 Washington DC

Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceMay 11, 2007 Washington DC

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceMay 16 , 2007Washington DC

A Novel Approach to Cardiometabolic Risk Reduction: Role of the Endocannabinoid

SystemSalisbury HospitalFebruary 17, 2007 Medical Grand Round

44


Acute Coronary Syndrome: ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceWashington DC

May 17, 2007

Coronary Interventions For Acute Coronary Syndromes: From Acute to Long-Term Management Research medical Center May 23, 2007 Kansas, MO

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceMay 23 , 2007 Washington DC

Coronary Interventions For Acute Coronary Syndromes: From Acute to Long-Term Management Mary Washington Hospital May 25, 2007 Fredericksburg, VA

Atherothrombosis Make The Connection: A Focus on Peripheral Arterial Disease. June 7, 2007 Arlington, VA

Applying Updated ACC/AHA Guidelines For Unstable Angina, NSTEMI and STEMI June20, 2007 Emergency Room, Kansas City, Missouri

Atherothrombosis: New Data on Acute Coronary Syndrome

Medical Grand RoundJune20, 2007 Kansas City, Missouri

Reducing Acute Risk in the Non-Stented Patient with ACS (NSTEMI)June20, 2007 Kansas City, Missouri

A Conversation on the Challenges to Caring for UA/NSTEMI PatientsSheraton PremierJune 25, 2007 Tyson’s Corner, VA

ARB's in Hypertension and Heart Failure: Consider the Evidence

June 27, 2007 Bethesda, MD

45


Acute Coronary Syndrome: Non- ST Elevation Myocardial InfartcionNational Expert Exchange TeleconferenceJune 27, 2007 Washington, DC

A Conversation on the Challenges to Caring for UA/NSTEMI Patients July 17, 2007 Virginia Beach, Virginia Understanding Hypertension and Type 2 Diabetic Nephropathy with Hypertension

July 17, 2007 New Jersey, NY

Treatment Strategies In Patients With Hypertension Who Are Not At Their Blood Pressure Goal

July 18, 2007 New Jersey, NY

Understanding Hypertension And Type 2 Diabetic Nephropathy With HypertensionJuly 18, 2007 River Pam, New Jersey

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceJuly 30 , 2007 Washington DC

Atherothrombosis Make The Connection:ACS, PAD and StrokeAugust 9, 2007 Springfield, Virginia

Management of Patients With STEMI: Applying the ACC/AHA GuidelinesMedical Grand RoundJanuary 11, 2007 Ogdensburg, New York

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceJuly 30, 2007 Washington, DC

Atherothrombosis Make the Connection: ACS, PAD and StrokeMedical AllianceAugust 9, 2007 Springfield, Virginia

46


Reducing Acute Risk in the Non-Stented Patient with ACS (NSTEMI) Medical Grand Rounds August 20, 2007

Atherothrombosis Make the Connection: New Clinical Data in Patients with ACSAugust 30, 2007 Delray Beach, Florida

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceSept. 5, 2007 Washington DC

Current and Emerging Strategies For the Management of Cardiometabolic RiskPriMed Update CME meeting Sept. 15, 2007 San Antonio, TX

Maximizing Efficacy, Minimizing Risk: Applying New Results From ACS Registries to Improve Patient OutcomesSaint Vincent Charity HospitalMedical Grand RoundsSeptember 26, 2007 Cleveland, Ohio

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceOctober 18, 2007 Washington, DC

Applying The ACC/AHA Guidelines for Acute Coronary Syndrome in Clinical PracticeMedical Grand RoundVirginia Hosptial CenterOctober 19, 2007 Arlington, Virginia

Acute Coronary Syndrome: Best Practices in Acute Coronary SyndromesNational Expert Exchange TeleconferenceOctober 31, 2007 Washington, DC

Current and Emerging Strategies for Reducing Cardiometabolic RiskGeorgetown University HospitalMedical Grand Round November 1, 2007 Washington, DC

47


Current and Emerging Strategies for the Management of Cardiometabolic RiskPriMed CME Update MeetingNovember 3, 2007 Orlando, Florida

Pre- Hospital and Emergency Room Mangement of STEMIMedical Grand RoundNovember 21 , 2007 VAMC, Wilmington, Delaware

CTA: Guidance of Cardothoracic SurgeryDecember 3, 2007Washington DC

CTA: Integration Into Cardiology Daily PracticeDecember 6,2007Washington DC

CTA: 2007 UpdateDecember 11, 2007Washington DC

CTA: Understanding The BasicsDecember 27,2007Washington DC

The Society of Endocrinology and Metabolism of TurkeyAdvancement in Type 2 Diabetes Management 4th Roses AssemblyCo-ChairmanApril 31-May 2, 2008Antalya, Turkey

The Pathogenesis and Clinical Impact of Atherosclerosis: A Case ScenarioMay 6, 2008Abu Dhabi, UAE

Update in the Treatment of Cardiovascular Disease SymposiumRole of CT angiography before and after CABG surgeryMay 9, 2008 Abu Dhabi, UAE

Update on Heart Failure HFSA GuidelinesAugust 19, 2008June 11, 2008SKMCAbu Dhabi, UAE

48


Peripheral Artery Occlusive Disease:An Interactive Case DiscussionAugust 19, 2008SKMCAbu Dhabi, UAE

Emirates Society of CardiologyHeart Failure In The Middle EastOctober 24, 2008Abu Dhabi, UAE

Smoking Cessation Work-ShopChairmanOctober 24, 2008 Abu Dhabi, UAE

Smoking Cessation Work-ShopHealth Risks of Smoking and Health Benefits of Smoking Cessation October 24, 2008-11-25 Abu Dhabi, UAE

Combination Therapy In Systemic Hypertension:October 31, 2008Limassol, Cyprus

Role of Beta Blockade in the Management and Prevention of Cardiovascular DiseasesChairmanNovember 14, 2008Dubai, UAE

Role of Beta Blockade in the Management and Prevention of Cardiovascular DiseasesCase StudiesNovember 14, 2008Dubai, UAE

Third International Congress of Cardiology: Multi-Modality ImagingCTA Angiography and CABGNovember 14, 2008Dubai, UAE

HsCRP: Past, Present and FutureNovember 23, 2008SKMCAbu Dhabi, UAE

First Arab Health : Clinical CardiologyChairmanJanuary 26 – 27, 2009Dubai, UAE

49


First Arab Health : Clinical CardiologyUpdate on Diagnosis and Management of Heart FailureJanuary 26, 2009Dubai, UAE

First Arab Health : Clinical CardiologyCase DiscussionJanuary 27, 2009Dubai, UAE

Update on Direct Renin InhibitorsFebruary 4, 2009Kuwait, Kuwait

Update on The Angiotensin Renin Aldosterone SyndromwFebruary 6, 2009Al Salama Hospital International SymposiumAbu Dhabi, UAE

Update on Heart Failure For Primary Care: Chairman Update on the Daignosis of Heart Failure Interesting Cases February 14, 2009 Abu Dhabi, UAE

KPI’s For Nurses March 1, 2009 SKMC Abu Dhabi, UAE

Cardiovascualr Disease Prevention Forum Moderator April 22, 2009 Abu Dhabi, UAE

Update on Beta Blockers Chairman Muscut, Oman April 24-25, 2009

Update on Direct Renin Inhibitors May 8, 2009 Abu Dhabi, UAE

Case Presentation Workshop May 9, 2009-05-17 Abu Dhabi, UAE

50


Update on the Diagnosis and Management of Systemic Hypertension May 10, 2009 Abu Dhabi, UAE

Daman Second Annual Meeting : Medical Error Workshop May 19 - 20, 2009 Abu Dhabi, UAE

Update on Cardiovascular TherapyMay 21, 2009 Larnaka, Cyprus

Direct Renin Inhibitors: New Therapeutic Options for HypertesionJune 5, 2009Dubai, UAE

Workshop on Cardiovascular Disease in Diabetic PatientsJune 6, 2009Abu Dhabi, UAE

Workshop on Cardiovascular Disease in Diabetic PatientsJune 6, 2009Abu Dhabi, UAE

Culture of Safety June 15, 2009 Abu Dhabi, UAE

Cleveland Clinic and SKMC Cardiovascular ConferenceCo-ChairmanJanuary 25-27, 2010Dubai, UAE

Cleveland Clinic and SKMC Cardiovascular ConferenceMangement of Lower Extremity Arterial Disease:Intervention vs. Medical ManagementJanuary 25, 2010Dubai, UAE

Cleveland Clinic and SKMC Cardiovascular ConferenceModerator: Heart Failure SessionJanuary 25, 2010Dubai, UAE

Cleveland Clinic and SKMC Cardiovascular ConferenceCase Presentations: Heart Failure SessionJanuary 25, 2010Dubai, UAE

51


Cleveland Clinic and SKMC Cardiovascular Conference How to Manage Patients with Type 2 Diabetes While Minimizing Cardiovascular Risks and Complications January 27, 2010Dubai, UAE

SKMC and Cleveland Clinic Quality ConferenceChairmanJanuary 27-28, 2010Dubai, UAE

SKMC and Cleveland Clinic Quality ConferenceTomorrow’s Medicine Today: The Elusive Role of Quality January 28, 2010Dubai, UAE

First Vascular Conference Morbidity and Mortality March 9, 2010 Abu Dhabi, UAE

First Vascular Conference Quality Measures in Cardiovascular Disease March 12, 2010 Abu Dhabi, UAE

Update on Hypertension Management with Fixed Dose Combination March 22, 2010 Damascus, Syria

Update on Hypertension Management with Fixed Dose Combination March 23, 2010 Aleppo, Syria

Oman Heart Association and Emirate Cardiac Society The 33 rd Sicetific Session The Jupiter Trial: Clinical Implications For Patient Management April 1, 2010 Muscat, Oman

Oman Heart Association and Emirate Cardiac Society The 33 rd Sicetific Session What Every Physician Needs To Know About Quality In Healthcare April 1, 2010 Muscat, Oman

Update on Hypertension Management with Fixed Dose Combination March 23, 2010 Aleppo, Syria

52


The Angiotensin-Renin-System-Efficay of Direct Renin Inhibitors: The Experience at the Gulf Region

May 14, 2010 Dubai, UAE

Clinical Hypertension Cases Discussion May 14, 2010 Dubai, UAE

Core Measures/Clinical Starter Sets EducationMay 31, 2010

Hospital Build: Quality & Accreditation ConferenceChairman

June 1-3, 2010 Dubai, UAE

EFQM WorkshopJune 2, 2010Dubai, UAE

New 4th Edition JCI StandardsJuly 26, 2010Abu Dhabi, UAE

International Safety GoalsMangement MeetingAugust 23, 2010SKMCAbu Dhabi, UAE

New 4th Edition JCI StandardsAugust 1, 2010Abu Dhabi, UAE




53


JCI Accreditation International Safety Goals August 31, 2010 Abu Dhabi, UAE International Safety Goals

Medical Staff MeetingSKMCSeptember 15, 2010Abu Dhabi, UAE

New 4th Edition JCI StandardsSeptember 30, 2010Abu Dhabi, UAE

Achieving Business Excellence Through EFQM ModelOctober, 2010Abu Dhabi, UAE

International Patient Safety ConferenceChairmanOctober 16-18, 2010Abu Dhabi, UAE

Benchmarking for HospitalsNovember, 2010Abu Dhabi, UAE

Infection Control UpdateChairmanJanuary 10, 2011Abu Dhabi, UAE

Update on the Mangement of Acute Coronary SyndromeJanuary 10, 2011Abu Dhabi, UAE

Accreditation and quality: Role of the Cath LaboratoryJanuary 11, 2011Abu Dhabi, UAE

Internatioanl Arab Health Cardiology ConferenceChairman

January 24-25, 2011 Dubai, UAE

54


Internatioanl Arab Health Cardiology ConferenceModerator: Quality Management in Healthcare

January 24, 2011 Dubai, UAE

Internatioanl Arab Health Cardiology ConferenceModerator: Management of Quality


Internatioanl Arab Health Cardiology Conference Determining the Role of Quality Department in Healthcare January 24, 2011 Dubai, UAE

Healthcare Quality Measure - Key Performance Indicators January 24, 2011 Dubai, UAE

Internatioanl Arab Health Cardiology ConferenceModerator: Healthcare Quality and Accreditation


Internatioanl Arab Health Cardiovascular ConferenceChairman

January 26-27, 2011Dubai, UAE

Internatioanl Arab Health Cardiolovascular ConferenceReactive Hyperglycemia and Cardiovascular Disease


Internatioanl Arab Health Cardiolovascular ConferenceModerator: Cardiovascular Disease, Risk Factors and Diabetes


Internatioanl Arab Health Cardiolovascular ConferenceModerator: Cardiac Imaging


Update on AccreditationSKMC

January 31, 2011Abu Dhabi, UAE

55


SKMC Leadership Development Day: Quality and AccreditationChairmanHilton HotelFebruary 13, 2011Abu Dhabi, UAE

SKMC Medical Staff Meeting: Quality and AccreditationMarch 7, 2011 Abu Dhabi, UAE

SKMC Medical Staff Meeting: Quality and AccreditationMarch 30, 2011 Abu Dhabi, UAE

SKMC JCI Opening Conference and Hospital OverviewApril 11, 2011 Abu Dhabi, UAE

SKMC JCI Data Use System TracerApril 12, 2011 Abu Dhabi, UAE

Quality Standards and Accreditation in Healthcare 2011Hospital BuildChairmanJune 13-15, 2011Dubai, UAE

Workshop: Achieving Healthcare Quality and Safety through Accreditation Chairman

June 15, 2011Dubai, UAE

AHS Healthcare Quality Conference Update on Patient Safety October 22, 2011 Abu Dhabi, UAE

Atrial, Fibrillation In Gulf November, 2011 Rome, Italy

Leadership Development DayQuality Presentation

December 14, 2011 Abu Dhabi, UAE

56


Third Annual SEHA Research ConferenceModerator

December 15, 2011 Abu Dhabi, UAE

Walk with the DocDecember 24, 2011Abu Dhabi, UAE

Echocardiography Master Class Initiative TEE of the Aorta January 13, 2012 Abu Dhabi, UAE

Third Middle East Quality Management in Healthcare Conference

Chairman January 23-24, 2012 Dubai, UAE

Third Middle East Quality Management in Healthcare ConferenceOpening Remarks by the Chair


Third Middle East Quality Management in Healthcare Conference Exploiting Challenges to Performance Improvement Agenda in the Region January 23, 2012 Dubai, UAE

Third Middle East Quality Management in Healthcare ConferenceModerator: Practical Examples of Quality Improvement Activities


Third Middle East Quality Management in Healthcare ConferenceOpening Remarks by the Chair


Third Middle East Quality Management in Healthcare ConferenceModerator: Key Concepts in Patient Safety


57


Drug Safety MENA SummitRecognizing the Importance of Drug Safety and its Growing Prominence across the Middle EastFebruary 26-29, 2012Dubai, UAE

Drug Safety MENA SummitRecognizing the Importance of Drug Safety and its Growing Prominence across the Middle EastChairman

Exploring strategies to ensure medication safety February 28, 2012 Dubai, UAE Drug Safety MENA Summit

Recognizing the Importance of Drug Safety and its Growing Prominence across the Middle EastChairman's opening and closing remarksModerator

Exploring strategies to ensure medication safety February 28, 2012 Dubai, UAE

Drug Safety MENA Summit Post Conference Work-Shop Urgency of Medication Reconciliation Work-Shop Leader February 29, 2012 Dubai, UAE

Culture of SafetySKMC

March 29, 2012 Abu Dhabi, UAE

Beta Blockers in Hypertension April 13, 2012

Kuwait, Kuwait

Heart Disease in WomenChairman

May 4, 2012 Abu Dhabi, UAE

Cardiovascular Global RiskChairman

May 8, 2012 Abu Dhabi, UAE

58


CEPHESUS StudyStrategies to Improve Goal AttainmentMay 15, 2012Dubai, UAE

Hypertension: Translating Evidence into Clinical PracticeMay 2012Abu Dhabi, UAE

Hospital BuiltChairman


Hospital BuiltLean Six Sigma: SKMC Primary Angioplasty Door-To-Balloon Time


Cardiovascular Prevention-Raised Expectations from Recent Outcome Trials: Are all ARBs Equal

June17, 2012 Abu Dhabi, UAE

How to Effectively Screen and Identify our at Risk Patients in the PCP Setting: Which tools and WhenJune17, 2012Abu Dhabi, UAE

Lean Six Sigma Symposium Chairman June 20,2012 Abu Dhabi, UAE

Ambulatory Blood Pressure Monitoring WorkshopFMC ClinicsJune 29, 2012Abu Dhabi, UAE

Ambulatory Blood Pressure MonitoringFMC ClinicsAugust, 2012Abu Dhabi, UAE

Update on Systemic HypertensionAHS SymposiumSeptember 1, 2012Abu Dhabi, UAE

59


Safety CultureSeptember 2, 2012Abu Dhabi, UAE

Lean Six Sigma: Door-to-Balloon PCI project September 2, 2012Abu Dhabi, UAE

Healthcare Management Workshop Zayed University September 15, 2012 Abu Dhabi, UAE

Center For Transforming Healthcare: International Hand Hygiene Pilot Project. Targeted Solution Tool (TST)JCI MeetingSeptember 25, 2012Frankfurt, Germany

Leadership and QualitySeptember 30, 2012Abu Dhabi, UAE

Center For Transforming Healthcare: International Hand Hygiene Pilot Project. Targeted Solution Tool (TST)JCI Executive BriefingOctober 3, 2012Dubai, UAE

Thrombosis Update October 9, 2012 Abu Dhabi, UAE

Third Annual Cold Chain MENA ChairmanOctober 15-18, 2012Dubai, UAE

Third Annual Cold Chain MENA ChairmanOctober 15-18, 2012Dubai, UAE

Ambulatory Blood Pressure Monitoring Management December 18, 2012

Abu Dhabi, UAE

60


Cardiovascular prevetion in CV risk patients: Recent evidence and guideline updatesJanuary 12, 2012Istanbul, Turkey

Workshop: ACE's vs. ARB's-Evidence, safety and tolerability January 12, 2012 Istanbul, Turkey

Arab Health Quality ManagementChairmanJanuary 28-29, 2013

Dubai, UAE

Arab Health Quality Management Lean and Six Sigma Methodology: Joint Commission Centre for Transforming Healthcare Hand Washing Case Study


Arab Health Quality Management EFQM - The Journey to Excellence


Arab Health Quality Management Infection Prevention: CLABSI (Central Line Blood Stream infection)


Arab Health Quality ManagementLean Six Sigma Primary Percutaneous Intervention: Door-to-balloon TimeJanuary 28-29, 2013

Dubai, UAE

Sharing best practcices in implementing JCI standardsSKMC experience in selecting the clinical indicatorsJanuary 28-29, 2013

Dubai, UAE

Drug Safety MENA Summit Organizing Committee

February 13, 2013 Yas Island, UAE

61


Drug Safety MENA Summit Developing Performance Improvement Activities to Improve Medication Safety February 13, 2013 Yas Island, UAE

Drug Safety MENA Summit Moderator February 13, 2013 Yas Island, UAE

SKMC Experience in Selecting the Clinical IndicatorsFebruary19, 2013Dubai, UAE

Contemporary Management of Acute Coronary Syndrome Februray 24, 2013 Al Ain, UAE

An Integrated Therapeutic Approach for Glucose and Cholesterol Management in Patients With Type 2 Diabetes

Februray 24, 2013 Abu Dhabi, UAE

Hypertension and Cardiovascualr Protection: What do the evidence tell us? Februray 27, 2013 Zayed Military Hospital Cardiology Grand Round Abu Dhabi, UAE

Patient Safety MOH Symposium Role of lean Six Sigma in health care Quality & Patient Safety March 7th, 2013 Dubai, UAE

First Abu Dhabi Cradiac and Vascular Disease ConferenceCradiovascular Disease: Quality Parameters


Hypertenion Symposium: Combination TherapyMarch 15, 2013Dubai, UAE

Gulf Lipids Expert Forum MeetingMarch 22, 2013Dubai, UAE

MEA Thrombosis expert forum TEFO March 22, 2013 Dubai, UAE

62


2nd International Conference on "Vitamin D Deficiency and its Health Consequence Moderator March 22, 2013 Abu Dhabi

Towards Better Patient Management Meeting Challenges of Cardiovascualr Disease March 24, 2013 Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013Scientific Advisory Committee

March 24-27, 2013 Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013Scientific Advisory Committee: Abstract Reviewer

March 24-27, 2013 Abu Dhabi, UAE

Patient Safety and Quality Congress Middle East 2013SKMC Study Tour Lead


Patient Safety and Quality Congress Middle East 2013Moderator: Leadership and Culture


Patient Safety and Quality Congress Middle East 2013Moderator: Leadership Management


Patient Safety and Quality Congress Middle East 2013Performance Improvement in Safety: Benefits of implementing Lean Six Sigma


Lean Six Sigma Outpatient pharmacy safety and waiting time April 13-14, 2013 Dubai, UAE

63


10th Hospital Design and Infrasctrutre Conference Smart Design and Quality of Care: Safety and Risk Mangement in Hospital Design June 4, 2013 Dubai, UAE

Fifth Middle East Health Quality Management Conference Chairman


Fifth Middle East Health Quality Management ConferenceLean, Six Sigma and Change Management in HealthcareJanuary 27, 2014

Dubai, UAE

Fifth Middle East Health Quality Management ConferenceEFQMJanuary 27, 2014

Dubai, UAE

International Medical Travel Exibition and ConferenceDebate Role of QualityMarch 5th 2014

Dubai, UAE MEIRC Conference

High Reliability in Healthcare April 2, 2014

Abu Dhabi, UAE

Healthcare Supply Chain Strategies Chairman April 7th, 2014 Dubai, UAE

Healthcare Supply Chain Strategies The Critical Stretegic Role Supply Chain plays In The Delivery of High Quality Care April 7th, 2014 Dubai, UAE

64


Abu Dhabi Quality Forum 2014Building a Quality System in HealthcareApril 28, 2014Abu Dhabi, UAE

Diabetes Mellitus SymposiumCardiovascular Burden in Type 2 Diabetes MellitusMay 2, 2014Abu Dhabi, UAE

ACLS Course Intsructor May 12-13, 2014 Abu Dhabi , UAE

Key Note Speaker Zayed University Healthcare Management May 24, 2014 Abu Dhabi, UAE

Regional Scientific Cardiovascular Exchange ForumChallenging Questions in HypertensionMay 30, 2014 Istanbul, Turkey

MENA Pharmaceutical Cold Chain Lean, Six Sigma and Change Management: Robust Performance Improvement- Tools to create and sustain world-class healthcare cold chainJune 4, 2014 Dubai, UAE

Update on The Management of DyslipidemiaNew ACC guidelinesJune 8, 2014Abu Dhabi, UAE

ACLS Course Intsructor June 9-10, 2014 Abu Dhabi , UAE

6th Middle East Quality Management in Healthcare ConferenceChairperson 26-27 January 2015Dubai, UAE

65


GCC Pharmaceutical CongressManaging the interface between phramacy and the hospital’s C-suiteSeptember 14, 2014Abu Dhabi, UAE

Cardiology Conference Co-Chairperson October 18, 2014 Abu Dhabi, UAE

Cardiology ConferenceUpdate on Heart Failure

October 18, 2014 Abu Dhabi, UAE

Patient SafetyOctober 19, 2014Abu Dhabi, UAE

Lean Six SigmaOctober 20, 2014Abu Dhabi, UAE

Dubai Healthcare ConferenceHigh Reliability in HealthcareOctober 23, 2014Dubai, UAE

LDL, BP & Cardiovascular Disease- Critical Questions & The EvidenceOctober 29, 2014Abu Dhabi, UAE

ACLS Provider CourseLead InstructorNovember 5-6, 2014Abu Dhabi, UAE

IHI Symposium Moderator November 16, 2014 Dubai, UAE

Innovative Strategies for Improving Patient CareScientific BoardNovember 24-27, 2014Abu Dhabi, UAE

66


Innovative Strategies for Improving Patient CareScientific BoardNovember 24-27, 2014Abu Dhabi, UAE

Innovative Strategies for Improving Patient CareLean Six Sigma in Healthcare WorkshopNovember 24, 2014Abu Dhabi, UAE

Innovative Strategies for Improving Patient Care Improving Quality and Patient Care through Innovative Leadership Strategies

November 25, 2014Abu Dhabi, UAE

Public Speaking TrainingDecember 10, 2014Dubai, UAE

Green Belt Lean Six Sigma Course Chairperson December 11-12, 2014 Dubai, UAE

6th Middle East Quality Management in Healthcare ConferenceChairman January 26-27, 2015Dubai, UAE

6th Middle East Quality Management in Healthcare ConferenceCME Co-Director January 26-27, 2015Dubai, UAE

6th Middle East Quality Management in Healthcare ConferenceModerator January 26-27, 2015Dubai, UAE

6th Middle East Quality Management in Healthcare ConferenceGemba Walks: A management improvement process for healthcare leadership January 26-27, 2015Dubai, UAE

6th Middle East Quality Management in Healthcare ConferenceHealthcare Kaizen: Sustainable Healthcare and Hospital ImprovementsJanuary 26-27, 2015

Dubai, UAE

67


6th Middle East Quality Management in Healthcare ConferenceTransforming Quality into Best Practice January 26-27, 2015

Dubai, UAE

Preventive Healthcare Forum 2015 Keynote speaker GCC region’s healthcare challenges on lifestyle related diseases January 26, 2016 Dubai, UAE

Update on Hypertension March 14, 2015 Abu Dhabi, UAE

Healthcare Supply Chain Strategies Building a Lean, Efficient, Patient-Centric Healthcare Supply Chain Chairman April 19-22, 2015 Dubai, UAE

Middle East Forum on Quality and Safety in Helathcare Institute for Helathcare Improvement Success Stories from the Region May 29-31, 2015 Doha, Qatar

Foundation in Patient Safety Training Program Institute for Healthcare Improvement Key Speaker September 2-3, 2015

Patient Safety Conference Chairman October4-6, 2015 Dubai, UAE

Patient Safety ConferenceTeam Work and Crew Resource Management

October4-6, 2015 Dubai, UAE

Patient Safety Conference Moderator October4-6, 2015 Dubai, UAE

68


Patient Safety ConferencePatient Safety Tools

October4-6, 2015 Dubai, UAE

Patient Safety Conference Critical Drivers For Successful Leadership In Quality Improvement Workshop Facilitator October4-6, 2015 Dubai, UAE

Clinical Echocardiography Echo in Heart Failure October 10-12, 2015 Dubai, UAE

ASQ Regional Quality Conference Chairman, Healthcare November 4-5 2015 Dubai, UAE

ASQ Regional Quality ConferenceCreating a Highly Reliable Health System

November 4-5 2015 Dubai, UAE

ASQ Regional Quality ConferenceChange ManagementNovember 4-5 2015

Dubai, UAE

ASQ Regional Quality ConferenceUpdate on InnovationNovember 4-5 2015

Dubai, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapy Conference Chaiman November 26-27, 2015 Abu Dhabi, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapyChaiman, Scientific Committee

November 26-27, 2015 Abu Dhabi, UAE

The First Annual Heart Failure Conference: An Update on Diagnosis and therapyChaiman, Organizing Committee


69


The First Annual Heart Failure Conference: An Update on Diagnosis and therapyUpdate on Heart Failure Guidelines


The First Annual Heart Failure Conference: An Update on Diagnosis and therapyThe Challenge of Heart Failure with Preserved Ejection Fraction


The First Annual Heart Failure Conference: An Update on Diagnosis and therapyReducing Heart Failure Readmission


HIMS Middle East Delighting Nurses through the consolidation of Clinically Relevant Information with SBAR December 12, 2016 Abu Dhabi, UAE

CPHQ Review CourseChairman

January 9-12, 2016 Abu Dhabi, UAE

6th Middle East Quality Management Conference Chairman January 27-28, 2016 Dubai, UAE

6th Middle East Quality Management Conference The Future of Quality Management- Resilience Healthcare January 27-28, 2016 Dubai, UAE

6th Middle East Quality Management Conference Practical Implementation of Lean Six Sigma Methodologies in Hospitals January 27-28, 2016 Dubai, UAE

6th Middle East Quality Management ConferenceInnovation and Creativity in Healthcare


SKMC ACLSCourse InstructorFebruary 8-9, 2016Abu Dhabi, UAE

70


Update on Anticoagulation Chairman March 11, 2016 Abu Dhabi, UAE

Role of Lean Six Sigma in Supply Chain Baraha Hospital March 13, 2016 Dubai, UAE

SKMC ACLS Lead Instructor April 4-5, 2016 Abu Dhabi, UAE

Update on Quality in SKMC Quality Grand RoundCleveland Clinic Main CampusMay 17, 2016Cleveland, Ohio, USA

71

BIBLIOGRAPHY:

1. A.Om, S. Ellahham, G.DiSciascio: Cholesterol Embolism: An Underdiagnosed Clinical Entity. Am Heart J 1992 Nov; 1 24(5): 1321-1326.

2. A.Om, S. Ellahham, G. W. Vetrovec: Radiation-induced Coronary Artery Disease. Am Heart J 1992 Dec; 124(6): 1598-1602.

3. A.Om, S. Ellahham, G. DiSciascio: Management of Cocaine-Induced Complications. Am Heart J 1993 Feb; 125 (Pt 1): 469-475.

4. A.Om, S. Ellaham, J. P. Ornato: Reversibility of Cocaine-Induced Cardiomyopathy. Am Heart J 1992 Dec; 124: 1639-1641.

5. A.Om, S. Ellahham, J.P. Ornato, G.W. Vetrovec: Cocaine-Induced Complications: Possible Relationship to Low Plasma Cholinesterase Enzyme. Am Heart J 1993 Apr; 125: 1114-1117.

6. A. Om, S. Ellahham, G.W. Vetrovec,C. Guard, S. Reese, J.V. Nixon: Risk of Left Ventricular Hypertrophy in Normotensive Cocaine Users. Am Heart J 1993 May; 125:1441-1443.

7. Shiran A, Goldstein SA, Zafar S, Ellahham S, Sears-Rogan P, Pinnow E, Lindsay J Jr: Determination of pretest probability for detection of a cardiovascular source of emboli by transesophageal echocardiography using clinical and transthoracic echocardiographic data. Am J Cardiol 1998;81:1506-1508.

8. Ran Kornowski, MD, Mun Hong, MD, Lior Gepstein,MD, Steven Goldstein, MD, Samer Ellahham MD, Slomo A. Ben-Haim, MD, DSc, Martin Leon, MD. Preliminary Animal and Clinical Experiences Using an Electro-Mechanical Endocardial Mapping Procedure to Distinguish Infarcted from Healthy Myocardium. Circulation 1998 Sep 15; 98(II): 1116-24.

9. Avinoam Shiran, MD; Steven Goldstein, MD; Samer Ellahham, MD; Gary Mintz; Augusto Pichard, MD; Ellen Pinnow, MS; Joseph Lindsay, MD. Accuracy of Two-Dimensional Echocardiographic Planimetry of the Mitral Valve Area Before and after Balloon Valvuloplasty. Cardiology 1998:90:227-230.

10. Bruce M. Smith, Samer Ellahham, Jon A. Satnford, Debra Kohlman Trigoboff, Maria T, Tupas-Habib, Hector Molina, Jedan Philips. Flow-Mediated Dilation in lower extremity vein grafts. Vascular Surgery 1999:33:595-602.

11. FuchsS, KornowskiR, Shiran A, Pierre A, Ellahham S., Leon MB., Electromechanical Chracterization of myocardial hibernation in a pig model. Coronary Artery Disease1999, 10 (3): 195-8.

72

BIBLIOGRAPHY:

12. Samer Ellahham. Bosentan and the Endothelin System in Congestive Heart Failure. Pharmacy Update.National Institue of Health 1999, January/February.

13. FuchsS, KornowskiR, Shiran A, Pierre A, Ellahham S., Leon MB. Electromechanical Chracterization of myocardial hibernation in a pig model. Coronary Artery Disease 1999, 10 (3): 195-8.

14. Baha Fadel, Samer Ellahham, MD; Matthew D. Ringel, MD; Joseph Lindsay, Jr., MD; Leonard Wartofsky, MD; and Kenneth Burman, MD. Hyperthyroidism and Heart. Clinical Cardiology. Clin Cardiol June 2000, 23(6):402-8.

15. Samer Ellahham, Eva Hausnerova, John S. Gottdiener. Intravenous Optison (FS069) Enhances Pulmonary Vein Flow Velocity Signals: A Multicenter Study. Clinical Cardiology 2000, 23 (2): 91-95.

16. Abriham Prasad, Theresa Tupas-Habib, William H. Schenke, Rita Mincemoyer, Panza JA,Waclawin MA, Samer Ellahham, Arshed A. Quyyumi. Acute and chronic angiotensin type1 receptor antagonism reverses endothelial dysfunction in atherosclerosis. Circulation 2000, 101(20):2349-54.

17. Samer Ellahham, Vincent Charlon, Zaid Abbasi, Karim A. Calis, Wassim Choucair. Bosentan and the endothelin system in congestive heart failure. Clinical Cardiology; 2000 (11):803-7.

18. Peter F. Kokkinos, Wassim Choucair, Page Graves, Vasilios Papademetriou, Samer Ellahham. Chronic Heart Failure and Exercise Training. American Heart Journal 2000,Volume 140 (1): 21-28.

19. Minna L. Hannuksela, MD and Samer Ellahham, MD. Benefits and Risks of Sauna Bathing. American Journal of Medicine, 2001, Volume 110(2):118-126.

20. Shiran, Avinoam ; Goldstein, Steven A.; Ellahham, Samer ; Leon, Martin B. ; Kornowski, Ran.Immediate effect of Biosense guided percutaneous direct myocardial revascularization with holmium:yttrium aluminium garnet laser on myocardial contractility assessed by transesophageal echocardiography. Coronary Artery Disease June 2000, 11(4):359-361.

21. Zaid A. Abassi, Joseph Winaver, Samer Ellahham, Aaron Hoffman. The Intrarenal Endothelin System and Hypertension. News In Physiological Sciences, 2001. Volume 16: 152-156.

22. Ran Kornowski, Shmuel Fuchs, Avinoam Shiran, Natama Summers, Matthew Pietrusewicz, SamerEllahham, Steven A.Goldstein, MartinB.Leon. Catheter-based electromechanical mapping to assess regional myocardial function: A comparative analysis with transthoracic echocardiography. Catheter Cardiovasc Interv. Mar 2001;52(3):342-7.

73

BIBLIOGRAPHY:

23. Arvind K. Sharma, Shadi M. Hamwi, Nidhi Garg, Marco T. Castagna. William Suddath, Samer Ellahham, Joseph Lindsay. Percutaneous Interventions in Patients With Cocaine-Associated Myocardial Infarction: A Case Series and Review. Catheterizartion and Cardiovascular Interventions 2002, Volume 56: 346-352.

24. Julian P.J. Halcox, KhaledR.A.Nour, Gloria Zalos, Rita Mincemoyer, Myron A. Waclawiw, Candido Rivera, Georgia Willie, Samer Ellahham,Arshed A. Quyyumi. The effect of sildenafil on human vascular function, platelet activation and myocardial ischemia. JAm Coll Cardiol.2002 , Oct 2;40(7):1232-40.

25. Saleet Jafri, Malda Bashi, Samer Ellahham: Usefulness of Lercanidipine, a new Calcium antagonist, for systemic hypertension. Opinion Article: Hypertension Today, November, 2003.

26. Samer Ellahham, MD, Yasmin Said, Phd, Edward Wegman, Phd. The Endocannabinoid System. A novel Approach to Cardiovascualr Risk Reduction. To be submitted to American Journal of Cardiology in 2008.

27. Anthony L. McCall, Samer Ellahham: What are the Potential Clinical Benefits of Insulin Therapy in Treating the Critically Ill?. Submitted to Clinical Cardiology.

28. Samer Ellahham, MD, Peter M. Mathisen, PhD, Chadi Ibrahim, MD:Intensive InsulinTherapy after Acute Stroke in Patients with Type 2 Diabetes. Submitted to Vascualr Medicine.

29. Samer Ellahham, MD. Role of Antiplatelet Agents in the Prevention of Atherothrombotic Events in High-risk Patients. Southern Medical Journal,

101(3):273-283, March 2008.

30. Samer Ellahham, MD, Gregory Trachiotis, MD, Judd Hollander, Kirk Garratt: A Safety Review of all Antiplatet Agents: Current and Future Agents. Submitted to The Journal of Emergency Medicine.

31. Anthony L. McCall, MD, PhD, Samer Ellahham, MD: Clinical benefits of insulin therapy in critically ill patients. Submitted to Clinical Cardiology 2008.

32. Peter M. Mathisen, PhD, Samer Ellahham, MD, Chadi Ibrahim, MD:Intensive Insulin Therapy after Acute Stroke in Patients with Type 2 Diabetes. Accepted Vascular Medicine Journal 2008.

33. Samer Ellahham, MD, Helmy Siragy: Suppression of the Renin-Angiotensin-Aldosterone System in Systemic Hypertension: Choice of Agents and Clinical Impact. Accepted in comprehensive online, continuing medical education (eCME) site –Cyberounds 2008.

34. Anthony L. McCall, MD, PhD, Samer Ellahham, MD: Molecular Mechanisms of Hyperglycemia in Critically Ill Patients: Rationale for the Clinical Benefits of Insulin Therapy.

34. Samer Ellahham, MD, Gregory Trachiotis, MD; Judd E. Hollander, MD; Kirk Garratt, MD: A Delicate Balance: Assessing the Safety of Upstream Initiation of Antiplatelet Therapy. Journal of Emergency Medicine.

74

BIBLIOGRAPHY:

35. Samer Ellahham, MD: Evolving Management Options For Hypertension: Risk Stratification, Various Populations and Special Situations in Middle East Asia 2010.

36. Samer Ellahham, MD: Cardiovascular Risk Assessment in the Patient with Diabetes: A Quick Reference Guide.

37. Samer Ellahham,MD: Insulin therapy in critically ill patients. Vascular Health and Risk Management, Nov 30, 2010.

38. Nicholas Turin, PhD, Samer Ellahham, MD: Venous Thromboembolism Prevention. Arab Health Journal, 2010.

39. Samer Ellahham, MD. "Molecular Mechanisms of Hyperglycemia and Cardiovascular-Related Events in Critically Ill Patients: Rationale for the Clinical Benefits of Insulin Therapy", Vascular Health and Risk Management, Nov 30, 2010.

40. Samer Ellahham, Samir Aljabbari, Tristan Mananghaya, Salama raji, Abdulmajeed Zubaidi: Reducing Door to- Balloon- Time for Acute ST Elevation Myocardial Infarction In Primary Percutaneous Intervention: Transformation using Robust Performance Improvement BMJ Qual Improv Report 2015;4: doi:10.1136

41. Honeymol John, Abdelrahman Nimeri, Samer Ellahham: Improved Surgical Site Infection (SSI) rate through accurately assessed surgical wounds. BMJ Qual Improv Report 2015;4: doi:10.1136.

42. Honeymol John, Abdelrahman Nimeri, Samer Ellahham: Improved Surgical Site Infection Paper accepted The ASHRM Annual Conference Committee (“Improving Mortality Reviews - A Four Year Journey in the Middle East.”) presented as Oral presentation and Abstract in Indiana, USA.

43. Haytham Taha, Salama J. Raji, Samer Ellahham , Nihal Bashir, Manar Al hanaee, Hessa Boharoon, , May AlFalahi. Improving venous thromboembolism risk assessment compliance using the electronic tool in admitted medical patients BMJ Quality Journal October 2015.

44. Ala'a Abuhejleh , Mohammed Dulaimi, Samer Ellahham. Using Lean management to leverage innovation in healthcare projects: case study of a public hospital in the UAE. BMJ Innov 2016;2:22-32.

45. Ala'a Abuhejleh , Mohammed Dulaimi, Samer Ellahham. Le Using Lean management to leverage innovation in healthcare projects: case study of a public hospital in U.A.E. International Journal of Advanced Research (2016), Volume 4, Issue 5, 896-898.

75

http://innovations.bmj.com/search?author1=Ala'a+Abuhejleh&sortspec=date&submit=Submit


http://qir.bmj.com/search?author1=May+AlFalahi,+MD&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Hessa+Boharoon,+MD&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Hessa+Boharoon,+MD&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Manar+Al+hanaee,+MD&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Nihal+Bashir,+MD&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Samer+Ellahham,+MD&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Salama+J.+Raji,+RN&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Haytham+Taha,+MD&sortspec=date&submit=Submit

BIBLIOGRAPHY:

46. Ala'a Abuhejleh, Paul Gardiner, Mohammed Dulaimi, Samer Ellahham. Exploring the role of Lean methodology as a tool for performance improvement in healthcare projects: an ethnographic case study in U.A.E. Submitted.

47. Haytham Taha, D, dana abdulhay, Neama Luqman, Samer Ellahham. Improving admission medication reconciliation compliance using the electronic tool in admitted medical patients. BMJ Qual Improv Report 2016;5: doi:10.1136/bmjquality.u209593.w4322.

76

http://qir.bmj.com/search?author1=Neama+Luqman&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=dana+abdulhay&sortspec=date&submit=Submit

http://qir.bmj.com/search?author1=Haytham+Taha&sortspec=date&submit=Submit


ABSTRACTS:

1. S. Ellahham, K. Nelson, MT. Schlutz, LF. Fox, JS. Hanrahan, MR. Taylor, DA. Julius, PK. Mohanty: Sleep-Disordered Breathing is Common in Cardiac Transplant Recipients (Presented at the First Annual Fellows' Conference on Transplantation, Chicago, 1991).

2. S. Ellahham, K. Nelson, MT. Schlutz, LF. Fox, JS. Hanrahan, MR. Taylor, DA Julius, PK. Mohanty: Sleep Apnea is Common in Cardiac Transplant Recipients (Presented at the 12 th

Annual Scientific Session of the International Society of Heart and Lung Transplantation, 1992).

3. S. Ellahham, K. Nelson, MT. Schlutz, JS. Hanrahan, A. Om, LF. Fox, MR. Taylor, DA. Julius, PK. Mohanty: Sleep-Disordered Breathing is Common in Cardiac Transplant Recipients (Oral presentation at the American College of Chest Physicians Meeting, 58 th

Annual Scientific Session, Alfred Soffer Research Award, 1992).

4. S. Ellahham, K. Nelson, MT. Schlutz, JS Hanrahan, A. Om, LF. Fox, MR. Taylor, DA Julius, A. Guerraty, PK. Mohanty: Blood Pressure and its Variability Following Human Heart Transplantation: Effect of Sleep and Sleep-Disordered Breathing (Oral presentation at the American College of Chest Physicians Meeting, 58th Annual Scientific Session, 1992).

5. A. Om, S. Ellahham, JP. Ornato, GW. Vetrovec, C. Guard, S. Reese, JV. Nixon: Risk of Left Ventricular Hypertrophy in Normotensive Cocaine Users (Poster Presentation at the American College of Chest Physicians eeting, 58th Annual Scientific Session, 1992).

6. A. Om, JV. Nixon, JP. Ornato, S. Ellahham, G.W. Vetrovec: Echocardiographic Evaluation of Valvular Predisposition for Endocarditis in Cocaine Users (Oral Presentation at the American College of Chest Physicians Meeting, 58th Annual Scientific Session, 1992).

7. S. Bajaj, VA. Luketic, ML. Shiffman, AJ. Sanyal, PP. Purdum, RA. Fisher, KB Brown, MC. Posner, R. Kohli, GW. Vetrovec, R. Reddy, S. Ellahham, JL. Tatum: Efficacy and Safety of Persantine Thallium Scanning (P-Thal) in the Evaluation of Patients Undergoing Orthotopic Liver Transplantation (OLT); (Poster Presentation at the American College of Chest Physicians Meeting, 58th Annual Scientific Session, 1992).

8. S. Bajaj, C. Crandall, H. Ibrahim, G. Vetrovec, G. DiSciascio, S. Ellahham, D. Salter, A. Gueratty, PK. Mohanty: Clinical Significance of Coronary Collateral Circulation in Cardiac Transplant Recipients (Poster Presentation at the American Heart Association Meeting, 65th Annual Scientific Session, 1992).

77

9. A. Om, S. Ellahham, JP. Ornato, GW. Vetrovec: Cocaine-Induced Complications: Possible Relationship to Low Plasma Cholinesterase Enzyme (American College of Cardiology Meeting, 42nd Annual Scientific Session, 1993).

10. A. Om, S. Ellahham, R. Reddy, S. Bajaj, D. Romhilt, R. Quint, JL. Tatum: Underestimation of Extent of Coronary Artery Disease on Dipyridamole Thallium Tomographic Scintigraphy in the Presence of ST Segment Depression (International Conference on Nuclear Cardiology, France, April 1993).

78

ABSTRACTS:

11. S. Bajaj, C. Crandall, G. DiSciascio, J. Tatum, S. Ellahham, H. Ibrahim, A. Guerraty, G. Vetrovec, D. Salter, PK. Mohanty: Characterization of Coronary Collateral Circulation in Cardiac Transplant Recipients (XVth Congress of The European Society of Cardiology, 1993).

12. A. Shiran, S. A. Goldstein, S. Ellahham, P. Sears-Rogan, E. Pinnow, J. Lindsay, Jr.. TEE for Cardiovascular Source of Emboli: Determination of Pretest Probability Using TTE and Presence of Atrial Fibrillation . JACC: Volume 29/ Number 2 (Supplement A),526 A, February 1997.

13. Samer Ellahham, Mihaela Tebeica, Steven Goldstein, Augusto Pichard, Joseph Lindsay. Safety of transesophageal-guided balloon mitral valvuloplasty in patients with atrial thrombi (Research award and poster presentation, American College of Physicians, District of Columbia Meeting, 1997).

14. Samer Ellahham, Mihaela Tebeica , Steven Goldstein, Augusto Pichard, Joseph Lindsay. Transesophageal Echocardiographically - Guided Balloon Mitral Valvuloplasty is Safe in Selected Patients with Left Atrial Thrombi (Poster Presentation, American Society of Echocardiography Meeting, June,1997).

15. Mihaela Tebeica, Samer Ellahham, Ellen Pinnow, Joseph Lindsay, Steven Goldstein, Augusto Pichard. Echo Score For Balloon Mitral Valvuloplasty Needs To Be Reevaluated. (Poster Presentation, American Society of Echocardiography Meeting, June,1997).

16. Jorge Cheirif, Douglas Segar, Eva Hausner, David Bach, Samer Ellahham, Miguel Zabalgoitia. FS069 Greatly Improves the Diagnostic Utility of Ultrasound for Left Ventricular Function. (Poster Presentation, American Society of Echocardiography Meeting, June,1997).

17. M.Karl, S. Ellahham, R. Oskoui, L. Wartofsky, and K.D. Burman. Thyrotoxicosis Associated with Rapidly Reversible Low-Output Heart Failure and Dilated Cardiomyopathy (Poster Presentation, 79th Annual Meeting of The Endocrine Society, June 1997).

18. A. Shiran, MD; S .Ellahham, MD; E. Pinnow, MS; A. Pichard, MD;J. Lindsay Jr., MD; SA Goldstein, MD. Accuracy of planimetry for assessment of mitral valve area after balloon valvulotomy (Poster Presentation, 63rd Annual International Scientific Assembly of the American College of Chest Physicians, October 1997).

19. Mihaela Tebeica, Joseph Lindsay Jr, Ellen Pinnow, Samer Ellahham, Steven Goldstein, Augusto Pichard. Echocardiographic Score For Mitral Balloon Valvuloplasty Needs To Be Reevaluated (Poster Presentation, 70th Scientific Sessions of The American Heart Association, November1997).

20. Momina Mastoor, Yvonne Bonnet, Ellen Pinnow, Samer Ellahham, Joseph Lindsay Jr., Augusto Pichard. New Devise Angioplasty: Gender Differences and Relation to Outcome. 47th Annual ACC Meeting, Atlanta, Georgia, March 1998.

79

ABSTRACTS:

21. Momina Mastoor, Samer Ellahham. A rare combination of anti-phospholipid antibody and factor V mutation. American College of Physicians, Washington DC, May 1998.

22. Momina Mastoor, Samer Ellahham. Pitfalls in echocardiography-A case of a hiatal hernia mimicking an extracardiac mass. American College of Physicians, Washington DC, May 1998.

23. Samer Ellahham, MD, Joseph Lindsay, MD. Safety of Arbutamine Stress Imaging in Patients > 70 years. Poster presentation, American Society of Echocardiography Meeting, San Francisco, June 1998.

24. Abhiram Prasad, Suresh Narayanan, Rita Mincemoyer, National Institute of Health, Bethesda, MD, Theresa Tupas-Habib, Samer Ellahham, Washington Hospital Center, Washington DC; Arshed A.Quyyumi, National Institute of Health, Bethesda, MD. Acute and Long Term Effects of Angiotensin Type I Receptor Inhibition on Endothelial Dysfunction in Atherosclerosis. Oral presentation, 71st Scientific Sessions, American Heart Association Meeting, Dallas, Texas, November 11, 1998.

25. Samuel Fuchs, Ran Komowski, Avinoam Shiran, Samer Ellahham, Anthony Pierre, Mun K. Hong, Martin B Leon, Washington Hospital Center, Washington, DC. Electromechanical Characterization of Chronic Experimental Myocardial Ischemia in a Pig Model. JACC, February 1999.

26. Samer Ellahham, Wassim Choucair, Ellen Pinnow, Augusto Pichard, Joseph Lindasy. Is Echo Score the Best Predictor of Successful Transcatheter Balloon Mitral Valvuloplasty? Washington Hospital Center, Washington DC. American Society of Echocardiography, 10th Annual Scientific Sessions, June 1998.

27. Bruce M. Smith, Samer Ellahham, Jon A. Satnford, Debra Kohlman Trigoboff, Maria Tupas-Habib, Hector Molina, Jedan Philips. Flow-Mediated Dilation in lower extremity vein grafts. Society for Clinical Vascular Surgery, 27th Annual Symposium on Vascular surgery, Lake Buena Vista, Florida, 1999 .

28. Samer Ellahham, Theresa Tupas-Habib, Abhiram Prasad, Suresh Nara Yana, Rita Mincemoyer, Arshed A. Quyymi. Acute and Long Term Effects of Angiotensin Type I Receptor Inhibition on Endothelial Dysfunction in Atherosclerosis. NAAMA 16th International Convention, Beirut, Lebanon, July 1999.

29. Samer Ellahham, Mihaela Tebeica , Steven Goldstein, Augusto Pichard, Joseph Lindsay. Transesophageal Echocardiographically - Guided Balloon Mitral Valvuloplasty is Safe in Selected Patients with Left Atrial Thrombi . Oral Presentation, NAAMA 16th International Medical Convention, Beirut, Lebanon , July 1999.

30. Samer Ellahham, Avionam Shiran, Pamela Sears-Rogan, Joseph Lindsay Jr.,Steven Goldstein, Martin Leon, Ran Kornowski. Catheter-Based Direct Laser Myocardial Revascularization Using the Biosense TM System Preserves LV Function and Improves Diastolic Function and Ischemic Mitral Insufficiency. Eleventh Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington DC, September 1999.

80

ABSTRACTS:

31. Samer Ellahham, Avionam Shiran, Steven Goldstein, Martin Leon, Ran Kornowski Kornowski. Immediate Effect of Percutaneous Direct Myocardial revascularization With Holmium: YAG Laser on Myocardial Contractility Assessed by Transesophageal Transesopahgeal Echocardiogarphy. Eleventh Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington, DC, September 1999.

32. Avionam Shiran, Steven A. Goldstein, Wassim Choucair, Samer Ellahham. Immediate Effect of Percutaneous Direct Myocardial Revascularization With Holmium: YAG Laser on Myocardial Contractility Assessed by Transesopahgeal Echocardiogarphy. 72nd Scientific Sessions of the American Heart Association, Atlanta, Georgia, November 7-10, 1999.

33. Gabriel Adelmann, Neil Weissman, Lameh Fananapazir, Samer Ellahham, Zuyue Wang, Bernadette Falcon, Ellen Pinow, Kenneth Kent, Steven Goldstein. Early Dynamic Changes in Subaortic Pressure Gradients After Successful Alcohol Septal Ablation in Patients with Hypertertrophic Obstructive Cardiomyopathy. 12th Annual ASE Scientific Sessions, Washington, Seattle, June 2001.

34. Joost Bottenbley, Yasmin H. Said, Edward Wegman, Samer Ellahham and David Anderson: Relationship between Competitiveness of Colleges and Levels of Tobacco use, Joint Statistical Meetings, Salt Lake City, UT, July 29-August 2, 2007.

35. Health benefits and Economic Impact, Joost Bottenblehy and Samer Ellahham and Yasmin H. Said and Edward Wegman and Malda Bashi: Restriction of Trans Fatty Acids in Washington, DC Metropolitan Area, Joint Statistical Meetings, Salt Lake City, UT , July 29-August 2, 2007.

36. Samer Ellahham, Yasmin H. Said, Edward Wegman, and Rima Allaham: Effect of Intravenous Insulin Infusion on Coronary Artery Disease Joint Statistical Meetings, Salt Lake City, UT, July 29-August 2, 2007.

37. Samer Ellahham, Yasmin H. Said, Edward Wegman: Update on Cardiometabolic Risk Reduction: Role of the Endocannabinoid System, Joint Statistical Meetings, Salt Lake City, UT, July 29-August 2, 2007.

38. Anan Said, Yasmin H. Said, Samer Ellahham, Edward Wegman, David Anderson, and Joost Bottenbley: Tobacco Use and College Competitiveness: Assessing an Underlying Correlation, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

39. Effectiveness of an Endocannabinoid Antagonist in Reducing Cardiometabolic Risk, Samer Ellahham, Anan Said, Yasmin H. Said, and Edward Wegman, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

40. The Potential Health Benefits and Economic Impact on the Region, Anan Said, Samer

Ellahham, Yasmin H. Said, Malda Bashi, Edward Wegman, and Joost Bottenblehy Banning Trans Fatty Acids in the Washington, DC Metropolitan Area: Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

81

ABSTRACTS:

41. New Insights into Intravenous Insulin Infusion on Coronary Artery Disease, Samer Ellahham, Anan Said, Yasmin H. Said, Rima Allaham, and Edward Wegman, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

42. Antiplatelet agents in the prevention of atherothrombotic events, Samer Ellahham, Yasmin H. Said, Edward J. Wegman, Rima Allaham, and Malda Bashi, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

43. Effect of Intravenous Insulin Infusion on Coronary Artery Disease, Samer Ellahham, Yasmin H. Said, Edward J. Wegman, Malda Bashi, and Rima Allaham, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

44. Diabetes Mellitus and Obesity, Samer Ellahham, Yasmin H. Said, Edward J. Wegman, Malda Bashi, and Rima Allaham, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

45. Antiplatelet Agents in Acute Coronary Syndromes, Samer Ellahham, Rima Allaham, Yasmin H. Said, Edward J. Wegman, and Malda Bashi, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

46. Peripheral Arterial Disease and Diabetes Mellitus, Samer Ellahham, Rima Allaham, Yasmin H. Said, Edward J. Wegman, and Malda Bashi, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

47. Primary and Secondary Stroke Prevention, Samer Ellahham, Yasmin H. Said, Rima Allaham, Edward J. Wegman, and Malda Bashi, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

48. New Hyperglycemia Increases Hospital Morbidity and Mortality, Samer Ellahham, Yasmin H. Said, Rima Allaham, Edward J. Wegman, and Malda Bashi, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

49. Update on Cardiometabolic Risk Reduction: Role of the Endocannabinoid System, Samer Ellahham, Yasmin H. Said, and Edward Wegman, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

50. Insulin Infusion Therapy In Type 2 Diabetics Who Have Had An Acute Stroke, Chadi Ibrahim, and Samer Ellahham, Yasmin H. Said, and Edward Wegman, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

51. Statistics of Peripheral Arterial Disease, Samer Ellahham, Malda Bashi, Yasmin Said, Edward Wegman, and Rima Allaham, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

52. Statistics of Women and Heart Disease in United States, Samer Ellahham, Rima Allaham, Yasmin Said, Edward Wegman, Malda Bashi, Computing Science and Statistics, Interface 2007, Philadelphia, PA, May 2007.

82

ABSTRACTS:

53. The Health Benefits and Economic Impact of Restricting of Trans Fatty Acids: A Case Study in the Washington, DC Metropolitan Area, Yasmin H. Said, Edward J. Wegman, and Samer Ellahham, International Symposium on Business and Industrial Statistics 2007, University of Azores, Sao Miguel Island, Ponta Delgada, Azores, Portugal, August 18-20.

54. Pulmonary Artery Hypoplasia, Pulmonary Hypertension and Hypospadias in a 22 year-old male: H. Vincent Lawson MD and Samer Ellahham. ACP Convention, Washington DC November, 2007.

55. Outcomes of Bariatric Surgery at BMI Abu Dhabi compared to ACS NSQIP Bariatric Surgery Programs Awadelkarim Mohamed MD1, Eelaf El Hassan MD,, Karen McKenna RN, Mohammed Al Hadad MD3, Michel Bussieres MD3, Samer Ellahham MD, Wayne Wasden, Nicolas Turrin PhD, Nidal Dehni MD, Abdelrahman Nimeri MD.

56. Cohort & Outcomes of Bariatric Surgery at BMI Abu Dhabi compared to ACS NSQIP Bariatric Surgery Programs Abdelrahman Nimeri MD, Karen McKenna RN, , Mohammed Al Hadad MD, Michel Bussieres MD, Samer Ellahham MD, Wayne Wasden, Nicolas Turrin PhD, Nidal Dehni MD.

57. Cohort & Outcomes of Sheikh Khalifa Medical City (SKMC) compared to ACS NSQIP Hospitals Abdelrahman Nimeri, MD, Karen McKenna RN, Nidal Dehni MD, Michel Bussieres MD, Samer Ellahham MD, Mohammed Al Hadad MD, Wayne Wasden CPHQ, Nicolas Turrin PhD.

83

CONTRIBUTOR TO PUBLICATIONS

1. Beneficial effects of rosuvastatin alone and in combination with extended-release niacin in patients with a combined hyperlipidemia and low high-density lipoprotein cholesterol levels. The American Journal of Cardiology, Volume 91, Issue 11, Pages 1304-1310.

2. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. J Am Coll Cardiol, 1998; 32:746-752.

3. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial Hypertension; 2001; 37:12.

4. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet, Volume 359, Issue 9311, Pages 995-1003.

5. Rationale and Design of a Secondary Prevention Trial of Antibiotic Use in Patients after Myocardial Infarction: The WIZARD (Weekly Intervention with Zithromax [Azithromycin] for Atherosclerosis and Its Related Disorders) Trial. The Journal of Infectious Diseases, volume 181 (2000), pages S572–S578.

6. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. The Lancet, Volume 363, Issue 9426, Pages 2022-2031.

7. Characteristics of 9194 Patients with Left Ventricular Hypertrophy: The LIFE Study. Hypertension. 1998; 32:989-997.

BOOKS:

1. Jamie’s Heart. A coloring book for children dealing with simple preventive measures. Published in 2002.

2. Quality And Patient Safety at Sheikh Khalifa Medical City 2010. Published in 2011.

3. PATIENTS FISRT: QUALITY OUTCOMES SHEIKH KHALIFA MEDICAL CITY 2012. Published in 2013.

4. PATIENTS FISRT: QUALITY OUTCOMES SHEIKH KHALIFA MEDICAL CITY 2013. Published in 2015.

84

CARDIOVASCULAR RESEARCH:

Principal Investigator: A Multicenter, Multinational Study to evaluate the clinical utility and safety of the GenESA system to diagnose coronary artery disease in patients with known or suspected coronary artery disease.

Principal Investigator: A Comparative Study for the Clinical Evaluation of the Safety and Efficacy of Intravenously Administered FS069 vs. Albunex for Endocardial Border Delineating, Left Ventricular Opacification, and D Doppler Signal Enhancement.

Principal Investigator: LIFE (Losartan Intervention For Endpoint reduction in hypertension). A triple-blind, parallel study to investigate the effect of losartan versus atenolol on the reduction of morbidity and mortality in hypertensive patients with left ventricular hypertrophy.

Principal Investigator : LIFE - ECG sub-study.

Principal Investigator : LIFE - Quality of life sub-study.

Principal Investigator: CONVINCE (Controlled ONset Verapamil Investigation Cardiovascular Endpoints). A ong-term prospective trial to determine whether a regimen starting with verapamil with a novel delivery system is at least as effective as a regimen starting with the choice of first-line "standardof care" (diuretic or beta blocker-as recommended by the Fifth Joint National Committee [JNC-V] on Detection, Evaluation, and Treatment of High Blood Pressure) in reducing the occurrence of fatal cardiovascular disease, Nonfatal stroke or nonfatal myocardial infarction in patients with primary hypertension followed over a four-to-six-year period.

Principal Investigator: A comparison of efficacy and safety of Mibefradil with Losartan in patients with mild to moderate hypertension.

Principal Investigator: A multicenter pilot study of expanded utilization of intravenous beta-blocker therapy in acute ischemic syndromes: The Esmolol Myocardial Ischemia Trial (EMIT).

Principal Investigator: Aggressive Diagnosis of Restenosis: The ADORE Study.

Principal Investigator: The WIZARD Trial: A randomized, double-blind, placebo controlled trial of the effect weekly azithromycin on the indicence of coronary artery disease in subjects with evidence of exposure to c. pneumoniae.

Principal Investigator: Routine versus Selective Exercise Treadmill Testing fter Angioplasty: The ROSETTA Observational Study.

Principal Investigator: Inhibition of MetalloProtease in a Randomized Exercise and Symptoms Study in Heart Failure: The IMPRESS Trial.

85


Principal Investigator: VALUE- A prospective, multinational, multicenter, double-blind, randomized, active-controlled trial in patients with essential hypertension to compare the effect of Valsartan 80 and 160 mg, with or without the addition of hydrochlorothiazide, once daily to that of amlodipine 5 and 10 mg once daily, with or without the addition of hydrochlorothiazide, on cardiovascular morbidity and mortality.

Principal Investigaror: CURE - Clopidogrel in Unstable Angina to prevent Recurrent Ischemic Events.

Principle Investigator: CAMELOT- Comparison of Amlodipine versus Enalapril to Limit Occurences of thrombosis.

Principle Investigator: SYMPHONY II- A Phase III, Multicenter, International, Randomized, Double- Blind, Aspirin-controlled Trial to Evaluate the Efficacy and Safety of two regimens with Xubix (Sibrafiban;Ro 48-3657), an Oral Platelet Glycoprotein Iib/IIIa Receptor Antagonist, as Therapy for the Long Term Prevention of secondary Vascular Events in Patients after an Acute Coronary Syndrome.

Principle Investigator: A Multicenter, Randomized, Double - Blind, Lisinopril and Placebo Controlled Trial of The Antihypertensive Efficacy and safety of Omapatrilat in Black Subjects with Mild to Moderate Hypertension.

Principle Investigator: A Randomized, Double - Blind, Placebo-Controlled, Concentration Escalating, crossover Study of BG9719 alone and in combination with Furosemide in Subjects with Moderate to Severe Congestive Heart Failure and mild to Moderate Renal Insufficiency.

Principle Investigator: A 12 week Randomized Double-blind Placebo-controlled Multicenter trial to Evaluate the Efficacy and Safety of ZD4522 (5 and 10 mg) and Atorvastatin 10mg) in the Treatment of Subjects with hypercholesterolemia.

Principle Investigator: MOXCON SR Moxonidine for Congestive Heart Failure The Effect of Sustained Release Moxonidine on Mortality and Morbidity in Patients with Congestive Heart Failure.

Principle Investigator: ENABLE-2 - Endothelin Antagonist Bosentan for Lowering cardiac Events in heart failure. A Double-Blind, Randomized, Placebo-controlled Study to Assess the Effects of R0 47-0203 (bosentan) on the Morbidity and mortality of patients with Chronic Heart Failure.

Principle Investigator: OVERTURE – Omapatrilat versus Enalapril Randomized Trial of Utility in Reducing Events. A Double-Blind, Randomized, Multinational Trial Comparing The Effects of Treatment with the Vasopepetidase Omapatrilat or the ACE inhibitor Enalapril on Major clinical Evants in Patients With heart failure.

Principle Investigator: A 24-Week Randomized Multicenter Trial to Evaluate the Efficacy and Safety of ZD4522 and NiaspanÔ Monotherapy, as Well as Selected Combinations of ZD4522 and NiaspanÔ, in the Treatement of Subjects With Type IIb orIV Hyperlipidemia.

86


Co - Investigator: Estrogen Status and Arrhythmias in Women..

Co-investigator:The The NOGA SYSTEM to detect chronic myocardial ischemia and to perform percutaneous myocardial revascularization, a pig in-stent restenosis model.

Co Investigator: The The NOGA SYSTEM to detect chronic myocardial ischemia and to perform percutaneous myocardial revascularization, a pig in-stent restenosis model.

Co - Investigator: Treatment of Patients with Non Thyroidal Illness.

Co-investigator: Replacement therapy in thyroid carcinoma patients.

Chart Review Committee: Strong Heart Study.

Contributor: Autologous CD34+ Cell Therapy Trial for Chronic Myocardial Ischemia (ACT34-CMI).

Principle Investigator: Anemia in Heart Failure study RED-HF Trial

Co-Investigator: Identification of patients with heart failure and PREserved systolic Function: an Epidemiologic Regional Study (I-PREFER).

87

VASCULAR BIOLOGY RESEARCH:

Principal Investigator: The Role of Angiotensin in the Pathophysiology of Atherosclerosis.

Principal Investigator: ENABLE-2- Endothelin Antagonist Bosentan for Lowering cardiac Events in heart failure. A Double-Blind, Randomized, Placebo-controlled Study to Assess the Effects of R0 47- 0203 (bosentan) on the Morbidity and mortality of patients with Chronic Heart Failure.

Principal Investigator: A Randomized, Double Blind, Placebo Controlled Trial of The Effects of Orlistat on Endothelium-Dependent Vasodilation in Obese Adults with Hypercholesterolemia: A Single Center pilot Study.

Principal Investigator: Effects of Endothelin receptor Blockade in Patients with Essential Hypertension and Congestive Heart Failure.

Principal Investigator: The Effect of Cyclooxygenase Inhibition on The Endothelial Function Hypercholesterolemic Patients.

Principal Investigator: A Randomized, Double Blind, Placebo Controlled Trial of The Effects of Orlistat on Endothelium-Dependent Vasodilation in Obese Adults With Hypercholesterolemia: A Pilot Single Center Study.

Principle Investigator: Study of PDE5 inhibition on myocardial ischemia and vascular function.

Principle Investigator: Blood pressure response to exercise and endothelial function.

Principle Investigator: A 12 week Randomized Double-blind Placebo-controlled Multicenter trial to Evaluate the Efficacy and Safety of ZD4522 (5 and 10 mg) and Atorvastatin (10mg) in the Treatment f Subjects with hypercholesterolemia.

Principle Investigator: Women’s Angiographic Vitamin and Estrogen(WAVE) Trial: Vascular Biology Sub-study.

Principle Investigator: A 24-Week Randomized Multicenter Trial to Evaluate the Efficacy and Safety ZD4522 and NiaspanÔ Monotherapy, as Well as Selected Combinations of ZD4522 and NiaspanÔ, in the Treatement of Subjects With Type IIb orIV Hyperlipidemia.

Co - Investigator: A Randomized, Double - Blind, Placebo Controlled Trial of The Effects of Idoxifene on Endothelium-Dependent Vasodilation in Postmenopausal women with hypercholesterolemia.

Co - Investigator: Effect of a Soy on Brachial Reactivity in Postmenopausal Women.

Co - Investigator: Phase1 Study of the Effects of Ascending Doses of Adenovirus Mediated Human FGF- 4 Gene Transfer in Patients with Stable Exertional Angina.

Co - Principal Investigator: Ultrasound Evaluation of Post-Implantation Endothelial Cell Function in Saphenous Vein Grafts Following Lower Extremity Bypass.

88

VASCULAR BIOLOGY RESEARCH:

Principal Investigator: A Double-Blind, Randomized Comparison Study of the Safety and Efficacy of Pioglitazone HCL or Glyburide in subjects with Type 2 Diabetes Mellitus post Acute Myocardial Infarction and/or Percutaneous coronary Intervention.

Principal Investigator: Omapatrilat Cardiovascular Treatment Assessment Versus Enalapril (OCTAVE).

Principal Investigator: Clinical Protocol for a Double-Blind, Randomized, Placebo Contolled Trial Evaluating the Safety and Efficacy of Eplerenone in Patients with Heart Failure Following Acute Myocardial Infarction.

Principal Investigator: A 6-week, Open-Label, Dose-comparison Study to Evaluate the Safety and Efficacy of Rosuvastatin Versus Atrovastatin, Cervistatin, pravastatin, and Simvastatin in Subjects With Hypercholesterolemia.

89

curriculum vitae - arado€¦ · web view6th middle east quality management conference chairman...

Documents